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Abstract 
Oxidative stress occurs when there is an imbalance between reactive oxygen and nitrogen 
species (RNOS) and the antioxidant system. In cardiac surgery patients and the critically ill 
there is an association between oxidative stress and morbidity and mortality. 
Extracorporeal circulation (ECC) encompasses cardiopulmonary bypass (CPB) which is 
used for cardiac surgery; extracorporeal membrane oxygenation (ECMO) which is used for 
cardio-respiratory support in the critically ill and haemodialysis which is used in patients 
with intermittent or end-stage renal failure. 
During ECC, the patient’s total blood volume is in direct contact with an artificial surface for 
extended periods. In addition, there is often pre-existing inflammation, surgical trauma 
and/or ischemia-reperfusion (I-R) injury, all of which are major activators for the increased 
production of RNOS. Concurrent decreases in the level of essential antioxidants and trace 
elements (such as selenium, zinc and copper) occur, which upset redox balance in favour 
of oxidative stress. The trace element selenium is required for the normal function of the 
antioxidant enzyme glutathione peroxidase (GPx). Despite in vitro and biochemical data 
suggesting that reinforcement of antioxidant activity by selenium supplementation might 
reduce excessive oxidative stress damage, there is conflicting evidence in clinical studies. 
The reason for failure of antioxidant supplementation in the clinical setting is currently 
unclear. 
We postulated that the ECC and its associated interventions such as transfusion, might 
have a larger impact on trace element loss, antioxidant function and the oxidative stress 
response than previously recognised. This led to the following questions: 
 
 What is the selenium level in healthy Queensland residents, and is this level similar 
to that reported in other parts of the world? 
 Does a patient’s pre-CPB or pre-ECMO circulating selenium level influence their 
outcome?  
 Does the ECC independently alter circulating selenium levels and the oxidative 
stress response?  
 Do other interventions during ECC, such as transfusion, alter circulating selenium 
and oxidative stress levels?  
 
 iii
This thesis focussed on oxidative stress and the trace element selenium, because 
oxidative stress is associated with poorer outcomes in cardiac and critically ill patients, and 
decreased selenium is independently associated with poorer outcomes. To answer the 
research questions outlined above, a series of experiments were designed and conducted, 
and they generated the following new information.  
The average selenium level in a Queensland blood donor population was defined at 1.09 
µmol/L (Chapter 3). In addition 88.5% of participants had a selenium level lower than the 
critical level required for maximal glutathione peroxidase activity, which has previously 
been determined to be between 1.14 – 1.27 µmol/L. Furthermore, this study generated 
novel information that packed red blood cells and buffy coat pooled platelets have very low 
levels of selenium (≤ 0.3 µmol/L). 
The effect of cardiopulmonary bypass circuits on circulating trace element levels was 
reported in Chapter 4. Reductions in selenium (17.1%), zinc (29%) and copper (18.2%) 
were recorded over a two-hour period. Coating the CPB circuit with albumin did not reduce 
the loss of trace elements. 
The effect of transfusing fresh or aged packed red blood cells (PRBC) on selenium and 
oxidative stress levels was compared using an ovine model (Chapter 5). Transfusion of 
PRBC (with low selenium content), into a healthy host reduced selenium and GPx activity 
and increased oxidative stress markers.  
The separate and combined effects of lung injury and ECMO on selenium levels and 
oxidative stress were investigated using an ovine model (Chapter 6). Our results revealed 
that the combination of acute lung injury and ECMO resulted in a 72% reduction in 
selenium after 24 hours, (1.36 to 0.38 µmol/L); however, oxidative stress markers were no 
worse than that associated with each separate intervention. 
Finally the association between selenium and post-operative atrial fibrillation (POAF) in 
low and high-risk cardiac patients was investigated (Chapter 7). Selenium levels were 
significantly lower pre-operatively and at all post-operative time points in high-risk patients 
and also in those who developed POAF. There was an association between longer 
intensive care stay at pre-operative selenium levels ≤ 0.7 µmol/L.   
 
Overall the key findings of this thesis were:  
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 Selenium levels in healthy Queensland blood donors were lower than the previously 
reported levels for other regions of Australia. 
 PRBC have very low levels of selenium. 
 CPB and ECMO independently reduced selenium levels.  
 The addition of ECMO to a host with lung injury compounded selenium reductions 
but did not increase oxidative stress.  
 Low selenium levels before cardiac surgery were associated with POAF.  
 Selenium levels lower than 0.7 µmol/L in cardiac surgical patients were associated 
with longer ICU stay.  
 
Collectively, the findings of this thesis answered the original questions. The knowledge 
and experience gathered from this journey has significantly improved my ability to design 
and conduct research, and my future research aspirations are detailed in chapter 8.  
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Convention for selenium units in this thesis 
The S.I. unit for selenium is µg/L, however, the chemical pathology laboratory that 
analysed our samples reported the results as µmol/L. To facilitate comparison of results, 
throughout this thesis and with the wider peer-reviewed clinical literature, selenium 
concentration is reported as µmol/L in preference to µg/L. Where published data is in the 
form µg/L it will be converted to µmol/L using the following formula (µg/L x 0.0127 = 
µmol/L). The exceptions to this are references to daily intake and Chapter 3 where the 
journal required use of the S.I. unit for selenium (µg/L). For this reason Chapter 3 retains 
the standard S.I. unit classification.
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Chapter 1 Introduction 
1.0 Background and rationale. 
Oxidative stress occurs when the level of pro-oxidant production exceeds the ability of the 
antioxidant system to maintain balance.2 Coupled to this antioxidant system is a select 
group of essential trace elements, which ultimately determine the ability of the antioxidant 
system to function normally and maintain redox balance. Cardiac surgery patients and the 
critically ill experience an oxidative stress response.3,4 Oxidative stress may be tolerated in 
patients with low-risk surgery or uncomplicated illness in the intensive care unit (ICU), 
however in patients with systemic inflammatory response syndrome, sepsis or multiple co-
morbidities it can compromise their outcome.5,6 For patients having cardiac surgery, one of 
the more common complications is post-operative atrial fibrillation (POAF). Increasing 
evidence suggests that one of the main factors in its development is increased oxidative 
stress during the surgical period.7,8 While blood contact with the cardiopulmonary bypass 
(CPB) circuit is known to trigger the inflammatory response,9 there is little information on the 
contribution of the circuit to the oxidative stress response. In critically ill patients with cardiac 
and/or respiratory failure and who are refractory to conventional medical therapy with a high 
risk of death, extracorporeal membrane oxygenation (ECMO) can be considered.10 Despite 
the great advantage offered by such therapies, the mortality associated with ECMO remains 
unacceptably high.10,11 The contribution of oxidative stress that develops during ECMO to 
the morbidity and mortality of these patients is poorly understood.  
Understanding what modifiable triggers of oxidative stress exist, specifically in the cardiac 
surgical and ECMO cohorts, may identify strategies that mitigate oxidative stress and 
potentially improve patient outcomes. An understanding of the oxidative stress response 
suggests that reinforcement of the antioxidant system should be a significant component of 
any such strategy. However, while select studies show improved outcomes in cardiac 
surgery and critically ill patients when antioxidants such as selenium, zinc, vitamin C and 
vitamin E are used, the majority of studies show no improvement, and the reason for this 
lack of benefit is unclear.12 Understanding the impact of CPB and ECMO circuits (and 
associated interventions such as transfusion) on trace element loss and subsequent 
oxidative stress responses may improve the design of future studies investigating the 
benefit of antioxidant supplementation.  
The most common forms of extracorporeal circulation (ECC) are CPB, ECMO and 
haemodialysis (HD). ECC involves the patient’s blood being directed through these artificial 
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circuits, which are known to stimulate the inflammatory response, (through contact 
activation), and increase oxidative stress.4,9 Additionally, recent studies in cardiac patients 
and the critically ill indicate clinically significant reductions in selenium levels, which are 
associated with increased morbidity and mortality.13,14 However, for patients having cardiac 
surgery or requiring ECMO, few studies have defined the interaction between selenium and 
oxidative stress and its effect on outcomes. Redox control is achieved by an appropriate 
antioxidant response and some of these antioxidants, such as glutathione peroxidase (GPx) 
and superoxide dismutase (SOD) require trace elements for normal function. As the focus of 
this thesis is selenium, the investigations are centred on the antioxidant GPx rather than 
SOD activity.  
 
Selenium reductions in the surgical 
and critically ill population are related 
to pre-, peri- and post-operative 
factors. The first pre-operative factor 
concerns dietary intake. Globally 
there is variation in selenium levels in 
the soil which influences selenium 
uptake into the bio-food chain,15,16 
and consequently there is significant 
variability in the selenium levels of 
individuals (Table 1-1).17 
Demographics on patients with 
ischemic heart disease reveal that in general they have poorer diets compared to healthy 
people,18 and consequently have an inadequate selenium intake. Other lifestyle aspects of 
cardiac disease also influence selenium levels. Tobacco use, obesity, diabetes, alcohol and 
high dietary fat intake, (which are cardiac risk factors), also contribute to selenium 
reductions.19 These observations suggest that cardiac surgical patients are more likely to 
present to hospital with low selenium levels and elevated markers of oxidative stress 
compared to the general population. The variability in soil selenium levels globally and 
corresponding selenium levels in any population makes interpretation of the impact of 
selenium levels on oxidative stress challenging. Hence, the first objective of this thesis 
involved defining selenium levels of the Queensland population.  
Table 1-1: Global selenium levels  
Selenium (µmol/L) Country 
0.53 Finland (Helsinki) 
0.60 New Zealand (Dunedin) 
0.92±0.18 Poland (Gdansk) 
0.93 Brazil (Rio de Janeiro) 
1.03 W. Germany (Mainz) 
1.08 Sweden (Lund) 
1.09±0.17 Germany (Dresden) 
1.22±0.17 (men) Switzerland 
1.12±0.18 (women)  
1.24 Japan (Hiroshima) 
1.27 Iran (Tehran) 
1.30 Saudi Arabia 
1.47 England (Southampton) 
2.01 Canada (Toronto) 
2.72±2.08 Pakistan (Islamabad) 
(Adapted with permission 16) 
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In the peri-operative period of cardiac surgery a host of factors such as surgical trauma, 
blood contact with the CPB circuit, hyperoxia and reperfusion of the ischemic myocardium, 
are associated with increased reactive oxygen species (ROS) production.4 It has also been 
demonstrated that ROS levels are elevated at the end of CPB and that these elevated 
levels precede the peak inflammatory response, (which occurs from 3hr post-CPB).20 
Elevated ROS are associated with a host of post-operative complications, including POAF, 
reduced pulmonary function, acute kidney injury (AKI) and neurological sequela.21-24 During 
this period there are also concurrent reductions in selenium.13,25 One of the first studies to 
note such a reduction during CPB was an observational paediatric study of 59 patients.26 
There were no explanations for the selenium reductions given, and the levels were still 
lower than baseline 48 hours after surgery. In a clinical survey of 197 cardiac patients, 
investigators determined that pre-operative selenium levels before CPB can be used as a 
risk predictors of inflammation and mortality.14 While a prospective observational study of 60 
cardiac patients demonstrated that post-operative selenium levels are a predictor of multi-
organ failure (MOF).13 The cause for the intra-operative decrease in selenium likely involves 
a combination of dilution and acute phase transition. However, an additional explanation 
may lie within the CPB circuit itself, as these circuits are known to adsorb proteins as well 
as drugs.27,28 Given both pre- and post-operative selenium levels appear important in 
determining outcomes in cardiac patients,13,14,29 confirming if the CPB circuit adsorbs 
selenium will provide information to estimate ECC associated selenium loss and also 
indicate if supplementation should be considered. This question was investigated in chapter 
4 of this thesis. 
Patients requiring ECMO are a subset of the acutely critically ill and thus exhibit many of the 
same co-morbidities as this population (i.e. inflammation, sepsis, ischemia), all of which are 
known triggers of ROS production. While on ECMO support, the patient experiences 
continuous exposure to the ECC circuit, multiple transfusions and they may also be on HD. 
Each of these interventions may individually or cumulatively contribute to patient 
morbidity.30 There is still significant mortality associated with both veno-arterial (VA) and 
veno-venous (VV) ECMO, both during the course of ECMO itself and between successful 
weaning from ECMO and hospital discharge.11 This thesis applied an in vitro model of 
ECMO (Chapter 6) to elucidate the impact the foreign surface of the ECMO circuit or 
multiple transfusions have on acute and chronic trace element reductions, oxidative stress 
and outcomes on the host/patient.  
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1.1 Hypotheses 
The hypotheses of this PhD thesis are: 
 
To investigate these hypotheses in both CPB and ECMO the following studies were 
conducted: 
1: CPB circuits adsorb trace elements and increase oxidative stress. 
2: Transfusion of blood products is associated with a reduction in selenium and an 
increase in oxidative stress. 
3: ECMO therapy is associated with significant selenium loss that contributes to 
increased oxidative stress.  
4: High-risk cardiac surgery patient with low pre-operative selenium levels are more 
likely to develop POAF.  
Study 1: The first objective was to determine the selenium level in the healthy 
Queensland population (Chapter 3), to provide an accurate baseline (and local 
relevance), for the whole thesis.  
Study 2: In order to understand the impact of the cardiopulmonary bypass (CPB) circuit 
on trace element levels (hypothesis 1), an in vitro circuit was utilised (Chapter 
4). 
Study 3: In order to investigate the effect of blood transfusion on oxidative stress and 
trace element levels (hypothesis 2), an in vivo ovine model was utilised 
(Chapter 5). 
Study 4: In order to investigate the individual and combined effects of acute lung injury, 
ECMO and transfusion on the host’s oxidative stress and selenium level 
(hypothesis 3), an in vivo ovine model of ECMO was used (Chapter 6). 
Study 5: In order to investigate the association between oxidative stress, selenium levels 
and POAF (hypothesis 4), a prospective clinical study was conducted on high 
and low-risk CABG patients (Chapter 7). 
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Chapter 2  Literature review 
2.1. Publication incorporated as section of Chapter: Oxidative Stress 
during Extracorporeal Circulation 
 
McDonald CI, Fraser JF, Coombes, JS and Fung YL 
 
European Journal of Cardio-thoracic Surgery. 2014 Dec;46(6):937-40  
 
Accepted for publication 6th December 2013.  
 
ABSTRACT. There is an increased oxidative stress response in patients having cardiac 
surgery, haemodialysis or extracorporeal membrane oxygenation that is related to poorer 
outcomes and increased mortality. Exposure of the patient’s blood to the artificial surfaces 
of these extracorporeal devices, coupled with inflammatory responses, hyperoxia and the 
pathophysiological aspects of the underlying illness itself, all contribute to this oxidative 
stress response. Oxidative stress occurs when there is a disruption of redox signalling and 
loss of control of redox balance. Ongoing oxidative stress occurring during extracorporeal 
circulation results in damage to lipids, proteins and DNA and contributes to morbidity and 
mortality. This review discusses reactive species generation and the potential clinical 
consequences of oxidative stress during extracorporeal circulation as well as an overview of 
some current antioxidant compounds that are available to potentially mitigate the oxidative 
stress response.  
 
Keywords: Extracorporeal Circulation, Cardiopulmonary bypass, ECMO, dialysis, oxidative 
stress, antioxidants. 
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INTRODUCTION 
Oxidative stress has been attributed to increases in morbidity and mortality in cardiac 
surgical patients, the critically ill and patients requiring haemodialysis (HD). 3,31-33 These 
patients are exposed to various extracorporeal circulatory devices such as cardiopulmonary 
bypass (CPB), HD and extracorporeal membrane oxygenation (ECMO). Substantive 
evidence from CPB and HD studies indicates that extracorporeal circulation (ECC) 
stimulates the inflammatory response generating reactive nitrogen and oxygen species 
(RNOS) and overwhelming the endogenous antioxidants, resulting in increased oxidative 
stress.3,31,34 Through an understanding of the multiple factors that occur during ECC 
responsible for generating RNOS, strategies may be developed which mitigate or reduce 
their generation and thereby reduce the associated complications. This review examines 
oxidative stress during CPB, dialysis and ECMO, as well as common antioxidant 
supplements, which may mitigate this response leading to improved patient care.      
OXIDATIVE STRESS 
Definition and basic overview 
Oxidative stress can be defined as a “disruption of redox signalling and control”.2 Under 
normal physiological conditions RNOS play essential roles in cell signalling (secondary 
messengers), immunity and cellular defense.3 Both intra and extra-cellular levels of RNOS 
are controlled by antioxidant moieties to maintain this redox balance.3 However, during 
various chronic and acute illnesses, an increase in RNOS production and loss of redox 
control is responsible for tissue and cellular injury. For instance, disturbance of the 
intracellular redox environment can result in cell apoptosis, senescence and disrupted 
differentiation.35 There are three classical mechanisms by which RNOS exert their 
damaging effects, (i) peroxidation of lipids, (ii) denaturation of proteins or (iii) damage to 
deoxyribonucleic acid (DNA).3 (Figure 2-1)  
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Figure 2-1: Simplified mechanism of oxidative stress, cellular RNOS generation and 
antioxidant action of SOD and GPx. 
(i) Lipid Peroxidation 
Lipid peroxidation is an important component of oxidative stress and is linked to a number of 
diseases including aging, atherosclerosis, Parkinson’s disease, Alzheimer’s, diabetes 
mellitus, cataracts and rheumatoid arthritis.36,37 Lipid peroxidation alters membrane fluidity 
and permeability, sometimes irreversibly, resulting in physiologic changes such as altered 
ion gradients across the membrane.36 The lipids in cell membranes, particularly poly-
unsaturated fatty acids (PUFA’s), are susceptible to attack by various RNOS such as 
hydroxyl and peroxyhydrides.37 Typically, damage in these conditions is a multi-step 
sequence of events beginning with RNOS mediated extraction of hydrogen from the lipid 
molecule, creating a fatty acid radical that itself extracts a hydrogen atom from the 
neighbouring lipid molecule creating another fatty acid radical. This self-propagating phase 
no longer requires the presence of the initiating RNOS to continue and expand.37 Stopping 
the lipid peroxidation sequence requires the intervention of a “chain breaking” antioxidant, 
 
Key: O2•-Superoxide radical; H2O2-Hydrogen Peroxide; ONOO•-peroxy radical; OH•-hydroxyl 
radical; NO•-nitric radical; SOD-Superoxide dismutase; GPx-Glutathione peroxidase; GSH-
Glutathione; GSSG-oxidised glutathione; GSSG-R-Glutathione reductase; NADPH-Nicotinamide 
adenine dinucleotide phosphate (reduced); NADP+ - Nicotinamide adenine dinucleotide 
phosphate. 
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such as vitamin E, or for the fatty acid radical to react with another radical, “quenching the 
fire”.37  
(ii) Oxidative Protein damage  
Similar to lipids, proteins are also a major component of cell membranes as well as being 
part of various essential enzymes throughout the body. Proteins are susceptible to both 
direct and indirect damage from RNOS. The hydroxyl and nitrogen based radicals can 
damage various amino acids. Additionally proteins that contain sulfur in their structure (such 
as cysteine and methionine) are also susceptible to oxidative damage.3 Several RNOS can 
also interact directly with proteins disrupting membrane ion transport mechanisms or 
causing the inactivation of enzymes and amino acids.3 
(iii) Oxidative DNA damage 
DNA is normally a stable molecule, however in the presence of high concentrations of the 
radical hydroxyl, oxidative damage occurs.38 Oxidative DNA damage is associated with 
carcinogenesis, neurodegenerative diseases, cardiovascular disease and aging.36,38 
Uncontrolled increases in RNOS result in modification of DNA bases, single and double-
DNA breaks, loss of purines, damage to the deoxyribose sugar, DNA-protein cross-linkage 
and damage to the DNA repair system.38 Two of the most common base modifications 
include 8-oxo-7,8-dihydroguanine and 2,6-diamino-4-hydroxy-5-formamidopyrimidine.39 
Some oxidative DNA damage can either be prevented by antioxidants or repaired by 
various endogenous DNA repair enzymes. Conversely reduced antioxidant or trace 
elements levels can undermine repair mechanisms leading to permanent damage.38 40 
  
ANTIOXIDANT DEFENCE AGAINST OXIDATIVE STRESS 
The endogenous antioxidant response is a coordinated effort between enzymes, proteins 
and vitamins to remove, alter or inactivate excessive build-up of RNOS. This is a multi-
layered defence system and the exact nature of the antioxidant response is influenced by (i) 
the solubility of the antioxidant (lipid or water solubility), (ii) whether it is an enzyme/non-
enzyme and (iii) the relative concentration of specific antioxidants in cytosol, plasma or 
tissue.3  
From a redox point of view, the enzyme antioxidants represent the first line of defence in 
cells and plasma.3 These primary antioxidants include superoxide dismutase (SOD), 
glutathione peroxidase (GPx) and catalase.3 SOD enzymes are present in most 
extracellular fluids as well as aerobic cells within the mitochondria and cytosol. The function 
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of all forms of SOD is the dismutation of the superoxide radical (O2•-) to hydrogen peroxide 
(H202) (Figure 2-2. equation 1).3 The primary function of GPx is to catalyse the reduction of 
hydrogen peroxide to water (Figure 2-2. equation 2) at the expense of glutathione (GSH). 
GSH is oxidized in this process, forming GS-SG, and in the presence of glutathione 
reductase (GR), the GS-SG is reduced back to GSH at the expense of nicotinamide 
adenine dinucleotide phosphate oxidase (NADPH) (Figure 2-2. equation 3).3 Catalase is 
present in the peroxisomes of cells and predominantly plays a role in the enzymatic 
decomposition of hydrogen peroxide when hydrogen peroxide levels are high within the cell 
(Figure 2-2. equation 4).3  
 
 
Figure 2-2: Mechanism of action of SOD, GPx and Catalase. 
These antioxidant enzymes react directly with RNOS before they can react with lipids or 
proteins, thus preventing or delaying the generation of secondary and tertiary radicals. 
Trace metals are required for their normal functioning, i.e. selenium for GPx, copper/zinc or 
manganese for SOD and iron for catalase.41 The non-enzyme antioxidants include ß-
carotene, Vitamin E, vitamin C, glutathione and Co-enzyme Q, which act primarily as 
scavenger and chain breaking antioxidants.36,41 The potential benefits of various antioxidant 
supplements are discussed below. 
CLINICAL SIGNIFICANCE OF OXIDATIVE STRESS DURING ECC 
Cardiopulmonary Bypass. 
Patients with underlying atherosclerosis, diabetes or chronic kidney disease (with or without 
dialysis) have increased levels of inflammatory cytokines and oxidative stress before 
cardiac surgery relative to the normal population.31,33,36 In addition, cardiac surgery utilizing 
CPB is associated with systemic inflammation, ischemia-reperfusion and surgical trauma, 
which are all strong stimulants of RNOS generation resulting in increased oxidative stress 
during and after surgery (Figure 2-3).31,42 A growing body of evidence indicates that this 
oxidative stress response is a major contributor to complications such as post-operative 
Equation 1: 2O2•-+ 2 H+ → 1 → O2 + H2O2 
Equation 2: 2GSH (reduced) + H202 → [GPx] →GS-SG (oxidized) + 2H20 
Equation 3: GS–SG + NADPH + H+ → [GR] →2 GSH + NADP+ 
Equation 4: 2H202 → Catalase → 2H20 + 02 
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atrial fibrillation (POAF), acute kidney injury (AKI) and acute lung injury (ALI) after cardiac 
surgery.32,43,44  
 
 
 
When CPB is initiated, blood contact with the artificial surface of the ECC circuit elicits a 
systemic inflammatory response activating neutrophils, NADPH oxidase and xanthine 
oxidase causing an increased production of RNOS.31,45 The inflammatory response to the 
ECC circuit also causes an acute phase redistribution of these trace elements to tissues 
and away from the intravascular circulation.46 Concurrently, the ECC circuit adsorbs trace 
elements vital to the antioxidant response, specifically selenium and zinc.47 Mini-
extracorporeal circuits (MECC) have a smaller surface area relative to standard CPB 
circuits. Select studies have shown reduced circulating levels of C-reactive protein (CRP), 
TNF and (interleukin-6) IL-6 when MECC are used in cardiac surgery.48,49 Whether these 
reductions in inflammatory cytokines translate to a reduced oxidative stress response in the 
patient is unclear. Importantly though, MECC are not suitable for highly complex cardiac 
surgery, and in these patients inflammation and oxidative stress is expected to be higher 
when compared to low-risk elective coronary artery surgery patients. Modern CPB circuits 
are coated with a variety of “biopassive or bioactive” coatings designed to dampen the 
contact inflammatory response and reduce platelet adhesion. Only one study has detailed 
the inflammatory and oxidative stress response between seven different biocoatings 
commonly used in CPB circuits.50 They determined that patients on CPB circuits using 
Bioline™ and phosphorylcholine coatings exhibited lower inflammatory and oxidative stress 
levels than other commonly used coatings.    
Figure 2-3: Factors involved in oxidative stress during cardiac surgery. 
Key: CPB: cardiopulmonary bypass; SIRS: systemic inflammatory response syndrome; I-R: ischemia-
reperfusion; POAF: postoperative atrial fibrillation; AKI: acute kidney injury; ALI: acute lung injury; 
RNOS: reactive nitrogen and oxygen species; AOX: antioxidants. 
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Increased RNOS production also occurs during reperfusion of the ischemic heart with 
oxygenated blood following cardioplegic myocardial arrest during surgery.36,51 During I-R 
endothelial cells respond by producing xanthine oxidase, generating the superoxide 
radical.3,36 In addition I-R results in a decreased function of myocardial antioxidants, 
especially GPx.51 Increased myocardial oxidative stress (such as during I-R) causes 
impaired atrial contraction, altered energetics of the myofibrils and a reduction in the 
effective refractory period of the atria leading to POAF.52,53 Cardiac surgical operations are 
often managed with hyperoxic (pO2 > 200mmHg) anaesthesia and CPB. Hyperoxia has 
been shown to stimulate neutrophils and mitochondria to increase production of RNOS, 
especially in the lungs.54 While the lungs do receive some blood supply during CPB from 
the bronchial arteries, they are still at risk of ischemic injury.55 While there are no controlled 
studies of hyperoxia vs. normoxia and oxidative stress, it is plausible that hyperoxia, 
especially during reperfusion of the ischemic lung post aortic clamping, may contribute to 
the overall oxidative stress profile. Further studies are needed to determine if oxidative 
stress profiles and clinical outcomes are improved when using a normoxic CPB strategy.  
Cardiac surgical patients are frequently transfused with blood products. Packed red blood 
cell (PRBC) transfusions have been associated with increases in lipid peroxidation and 
oxidative stress in a small number of studies, presumably the consequence of a 
combination of the storage lesion, increased iron load and decreased antioxidant profile of 
the stored red cells.56,57 Some patients, especially those with more complex procedures 
such as aortic dissections, re-operations or aortic arch repairs, may require massive 
transfusion. Thus, the high number of PRBC transfusions may contribute to increased 
oxidative stress and compromise patient outcome. Platelet transfusions are not uncommon 
during cardiac surgery and mostly occur at the end of CPB, when the inflammatory 
response is already activated. Platelets are an important source of RNOS, primarily 
generating superoxide,58 and studies indicate that stored platelets similar to stored red cells, 
will undergo a time dependant storage lesion.59 Whether the transfusion of these platelets 
into a patient will affect the oxidative response has not been investigated.  
Haemodialysis 
HD is the most prevalent form of renal therapy for acute kidney injury in the critically ill/post-
surgical setting, or more commonly for chronic end stage renal failure.60 HD may be applied 
as conventional HD in the chronic setting or in a variety of modes for the acute setting (i.e. 
slow low efficient dialysis (SLED), slow continuous ultrafiltration (SCUF) and continuous 
veno-venous haemofiltration (CVVH)). All forms of HD utilise artificial circuits to remove 
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uremic waste and restore fluid and electrolyte balance. These circuits can have surface 
areas approaching mini-CPB circuits, and thus, are also associated with the activation of the 
coagulation and inflammation systems in a similar fashion, if not magnitude, to CPB.61   
Evidence that patients with renal failure have increased oxidative stress and decreased 
antioxidant responses both pre- and post-HD has been reviewed previously.62 Increases in 
oxidative stress after HD are associated with increased morbidity, (specifically 
cardiovascular disease) and mortality. The mechanisms of increased oxidative stress in 
these patients is multi-factorial and includes the renal disease itself, reduced antioxidant 
intake associated with malnutrition, loss of antioxidants during HD and the interaction 
between blood and the HD membrane.63 Additionally, the overall uremic state of the patient 
and haemo-incompatibility of circuits (polysulfone vs. cuprophane) are recognised as the 
major factors associated with both inflammation and oxidative stress.64  
Attempts to reduce the oxidative stress response due to blood contact with the dialysis 
circuit have been investigated using dialyser membranes that are more biocompatible. A 
2006 meta-analysis of 14 studies using vitamin E coated cellulose filters demonstrated an 
overall reduction in lipid peroxidation levels as measured by malondialdehyde (MDA), 
thiobarbituric acid reactive substances (TBARS) and low density lipoproteins.65 More 
recently, companies have coated polysulfone dialysers with vitamin E. Early findings have 
demonstrated better reductions in oxidative stress markers as well as reduced markers of 
inflammation.66 Further studies are needed to determine if reductions in oxidative stress 
levels during HD equates to better clinical outcomes. 
Extracorporeal Membrane Oxygenation 
ECMO is a rescue therapy for critically ill patients with potentially reversible cardiac and/or 
respiratory failure refractory to maximal conventional medicine.30 In spite of the potential 
benefits of ECMO in these patients, the prolonged exposure of the blood to these artificial 
circuits is associated with a variety of deleterious pathophysiological changes and 
complications.30  
There are currently very limited data on oxidative stress or antioxidant changes during 
ECMO, either clinically or experimentally. In a rabbit model of ECMO, increases in lipid 
peroxides were measured just after initiation in plasma and lung tissue.67 However, in a 
lamb model of short duration ECMO, no increases in lipid peroxides were detected, instead 
there were decreases in the antioxidant enzymes SOD and GPx.68 In the only clinical study 
investigating oxidative changes during ECMO, Hirthler et al showed increases in lipid 
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peroxides for up to 96 hrs after initiation of ECMO in a paediatric population.69 In this study 
non-survivors had increasing lipid peroxidation levels, while the levels plateaued after 24 
hours in the survivor group. There are significant differences between paediatric and adult 
ECMO, such as the ratio of ECMO surface area to body size. This aspect limits the ability to 
translate paediatric or small animal ECMO studies to the adult. To date there are no studies 
investigating oxidative stress in adult ECMO.     
Despite a lack of current data on the oxidative stress response in the adult ECMO 
population, there is considerable evidence from the critically ill population to indicate that 
oxidative stress is a major contributor to morbidity and mortality. Specific RNOS triggering 
events in the critically ill, which are especially relevant to the ECMO patient, are listed in 
Table 2-1. Two of these triggers are specifically relevant in the ECMO patient. The first 
major trigger, unique to patients on ECMO, is the initial and continued contact of whole 
blood with the ECMO circuit for days and weeks. Initial contact of blood with the ECMO 
circuit elicits a systemic inflammatory response (SIRS) as measured by increased 
production of cytokines such as IL-6.70 Studies in CPB show that patients with SIRS also 
have a disturbed redox equilibrium,71 which is a result of both increased RNOS production 
and decreased antioxidant levels. Hence, it is reasonable to also expect oxidative injury via 
this mechanism during ECMO. However, whether prolonged exposure to the ECMO circuit 
continues to increase oxidative injury is unknown.  
The second important trigger 
during ECMO is hyperoxia,77 
which may be particularly 
relevant in the VV-ECMO 
patient. During VV-ECMO, 
hyperoxic blood is returned 
directly to the venous system 
where it flows directly to the 
damaged pulmonary 
vasculature. Worsening lung 
function as determined by 
radiographic evidence of consolidation is evident within the first 24-48 hours of ECMO 
initiation (Figure 2-4). Limited experimental data suggests that hyperoxia in this setting may 
facilitate neutrophil sequestration to the lungs, leading to increased pulmonary endothelial 
Table 2-1: Potential triggers for RNOS during ECMO 
 
Potential triggers for increased RNOS generation during ECMO. 
Exposure to ECC (ECMO circuits 72, Dialysis 34) 
Systemic Inflammatory Response Syndrome 73 
Acute Respiratory Distress Syndrome 44 
Hyperoxia 54 
Mechanical ventilation 74 
Sepsis 75 
Ischemia-Reperfusion 76 
Transfusion 56,57 
Sequestration of antioxidant trace elements by the ECMO circuit 47 
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RNOS production and lipid peroxidation.54,67 Given the ability of these oxidative stress 
triggers to increase ECMO morbidity and mortality, it highlights the need for detailed 
oxidative stress studies in this cohort.  
 
Figure 2-4: Chest X-ray showing lungs before VV-ECMO (L) and 24-h after 
initiating VV-ECMO (R). 
 
ANTIOXIDANT SUPPLEMENTS TO REDUCE OXIDATIVE STRESS.  
The endogenous antioxidant defence system consists of both intra- and extra-cellular 
antioxidants that regulate the quantity of RNOS. There are considerable disturbances to this 
antioxidant system during critical illness as well as during cardiac surgery and HD. 
Specifically, there are reductions in antioxidant micronutrient levels such as selenium, zinc 
and vitamin C.78 Some of these reductions during ECC are a due to (i) an acute-phase 
redistribution as a result of the increased inflammatory response, (ii) adsorption to the ECC 
circuit and (iii) excretion in bodily fluids/dialysate.47,78,79 In addition to providing appropriate 
nutritional support in patients exposed to ECC, replacement of these antioxidant 
micronutrients may be a relatively low cost and safe intervention to mitigate the effects of 
oxidative stress.78,80 Various compounds with antioxidant properties that have been 
investigated, either as individual supplements or in combination therapy, are discussed in 
brief below. 
Selenium 
Selenium is an essential trace element that is incorporated into selenoproteins, some of 
which have antioxidant properties (i.e. GPx, Selenoprotein P and thioredoxin).81 There are 
many potential benefits to selenium supplementation but most are centred around its link 
with increasing the activity of the antioxidant GPx.82 The relationship between GPx and 
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selenium is such that when selenium levels fall below plasma levels of 90 - 100 µg/L there 
is a direct reduction in GPx activity.82 Significant reductions in selenium occur after cardiac 
surgery and dialysis.13,79 In both these patient groups the reductions are inversely 
associated with increased complications and morbidity.13,83 Similarly, in critical illness 
(without ECMO), selenium reductions occur especially during sepsis, and are associated 
with adverse outcomes.84 Selenium supplementation has been investigated in cardiac 
surgical patients undergoing CPB 25 and in the critically ill.85 A recent meta-analysis of 
micronutrient use in the critically ill population (not on ECMO) concluded that the treatment 
effect of selenium supplementation was greatest in patients with more severe illness.80 It is 
worth noting that those benefits were only seen when doses were greater than 500 µg/day, 
a dose far in excess of the 50 - 70 µg/day recommended dose. Despite the inconsistent 
beneficial findings Visser et al have recommended that micronutrients, including selenium, 
should at least be given at the current recommended daily dosages in the critically ill as a 
safe and effective way to prevent clinical deficiencies.78 Additionally, the 2013 Canadian 
Clinical Practice Guidelines recommend the use of parenteral selenium in the critically ill.86  
Vitamin C 
Vitamin C (L-ascorbic acid) is an essential nutrient with potent hydrophilic antioxidant 
properties. It acts as an aqueous phase antioxidant that has the ability to stop the 
propagation of free radicals that cause lipid peroxidation, termed “chain breaking 
antioxidant”, and is also required for the regeneration of the oxidised form of a-
Tocopherol.87 Studies in surgical and critically ill patients indicate an acute reduction in 
plasma vitamin C levels that is explained only partly by increased antioxidant demand in the 
tissues.87 Levels are further decreased in patients that develop post-operative 
complications. The well-established link between oxidative stress and atrial fibrillation (AF) 
studies has led investigators to assess the preventative effect of vitamin C supplementation 
(isolated or combination therapy) on the development of POAF.87,88 Experimental and 
clinical evidence demonstrates a reduction in POAF following ascorbate supplementation.89 
A recent study demonstrated that the effect of vitamin C supplementation on POAF was 
more effective when given in association with ß-blockers compared to ß-blockers alone.90 
However, more studies are required to confirm these results.  
In dialysis patients, vitamin C deficiency has been reported after extended hours HD. 
Vitamin C supplementation in these patients has been shown to restore plasma levels and 
reduce levels of oxidative stress, as evidenced by markers of lipid peroxidation.91 Caution 
must be used, however, when considering vitamin C supplementation in patients with renal 
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disease, as vitamin C is metabolised to oxalate. Oxalate causes the build-up of calcium 
oxalate in tissues, which can have cardiovascular consequences.92 While there are no 
studies investigating the clinical outcome benefits of vitamin C supplementation during 
ECMO, it has been shown that supranormal doses of I.V. vitamin C in the critically ill can 
restore endothelial function and thereby modulate redox signalling.93 
Vitamin E 
Vitamin E (-tocopherol) is a fat-soluble antioxidant that reacts with lipid peroxides to 
prevent lipid peroxidation. It acts synergistically with vitamin C at the lipid-water interface of 
cell membranes where vitamin C can act as an electron donor to regenerate vitamin E.88 
Based on its known antioxidant properties, the ability of vitamin E to prevent cardiovascular 
disease has been investigated in a study of 9551 patients but found no positive effect in this 
regard.94 Although vitamin E levels are reduced during cardiac surgery and can be 
normalised with supplementation, another study showed that there was no reduction in lipid 
peroxidation after supplementation.95 Studies that have investigated the ability of 
prophylactic vitamin E to reduce POAF have also produced conflicting results. When used 
in isolation the results indicate that vitamin E has no protective effect,95 while studies using 
combination antioxidant therapy have shown reductions in POAF in the treatment groups. 
96,97 Such studies suggest a synergistic effect, which needs to be confirmed by more 
rigorous studies.  
Vitamin E supplementation has also been investigated during HD as a way of reducing the 
adverse effects associated with oxidative stress. One of the larger of such studies, the 
SPACE study,98 concluded that vitamin E supplementation in HD patients with 
cardiovascular disease reduced the incidence of myocardial infarction and other composite 
endpoints, but they did not measure markers of oxidative stress. A review of 25 studies 
where vitamin E supplementation was used and oxidative stress markers were measured 
found that in 20 studies there was a reduction in a variety of oxidative stress markers.63   
Zinc 
Zinc is a trace element important to many aspects of human health, including an essential 
role supporting SOD activity. Supplementation with zinc has been shown to improve plasma 
zinc levels, but it is unclear if it improves SOD activity. Transient zinc deficiencies occur 
after cardiac surgery, HD and during critical illness.99 Zinc levels have been shown to be 
inversely proportional to SOFA scores and organ failure in critical illness.100 However, we 
could find no studies demonstrating a mortality benefit when zinc supplementation was used 
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alone. Nevertheless, reports of toxic side effects are rare, and given the purported benefits 
of zinc supplementation in the mentioned patient populations, it is often added to the 
standard nutritional profile for many critically ill patients.  
N-acetylcysteine 
N-acetylcysteine (NAC) is a free radical scavenger antioxidant useful in chronic lung 
disease and has been shown to reduce RNOS and pro-inflammatory cytokine 
production.101,102 These properties have led to investigating the benefits of prophylactic NAC 
supplementation in cardiac surgical patients with specific aims to reduce the incidence of 
POAF.102 While selected studies such as this have shown improved outcomes in patients 
supplemented with NAC, a recent meta-analysis involving 1163 cardiac surgical patients 
concluded that the evidence did not support the use of NAC for the prevention of AKI.101 
Glutamine 
Glutamine is a non-essential amino acid that is metabolised to glutamate, a precursor to 
glutathione synthesis. Glutathione is the major endogenous antioxidant produced by cells 
and it exists mostly in the reduced form (GSH). The body has the capacity to synthesise 
sufficient glutamine under normal physiological conditions, however, significant reductions 
in glutamine occur during critical illness, after cardiac surgery and after prolonged 
dialysis.103 Despite these reductions, there is sparse data on the beneficial effects of 
glutamine supplementation during cardiac surgery. In the cardiac surgical population studies 
have demonstrated that glutamine supplementation maintains GSH activity and increased 
glutamine levels, but had no effect on organ dysfunction or length of stay in ICU.104 
Although high quality evidence supporting parenteral glutamine supplementation in the 
critically ill has recently emerged,105 we could find no studies solely investigating the effects 
of glutamine in ECMO patients. The recommendations from the Canadian Clinical Practice 
Guidelines for the critically ill have since updated their support for the “use of parenteral 
glutamine in the critically ill, except in those with multi-organ failure”.106  
Conclusion 
Oxidative stress has been shown to be clinically relevant to patient outcomes and this 
review has highlighted the mechanisms leading to increased oxidative stress in patients 
exposed to ECC, and discussed some antioxidant supplements commonly used to 
modulate this response. Other avenues for possibly controlling ECC induced oxidative 
stress include reducing ECC surface areas, designing circuits with better bio-compatibilities, 
implementing normoxia and investigating the effects of pulsatile flow (during CPB) on 
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endothelial RNOS production. In addition, there are a range of pharmaceutical compounds 
beyond the scope of this review (e.g. statins and antifibrinolytics), which also exhibit 
antioxidant properties. However, many of these interventions require further confirmation of 
efficacy. 
Redox control via antioxidant supplementation presents an attractive low risk and low cost 
intervention in this assault. Already the benefits of antioxidant supplementation have been 
reported in critically ill patients, leading to recent recommendations for the use of antioxidant 
supplements, specifically glutamine (and possibly selenium). Despite the theoretical benefits 
of antioxidant therapy, the available evidence has challenged the practicality of 
implementing widespread antioxidant supplementation in patients exposed to ECC. This 
evidence has suffered from, poor study design, low sample numbers, heterogenous patient 
groups and a lack of consensus as to the best biomarker for oxidative stress. Thus, 
improved prospective randomised controlled trials of antioxidant supplementation are 
needed to define not only the most appropriate patient groups, but also antioxidant dosing 
and timing.  
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2.2. Supplementary review material relevant to thesis not included in 
publication 
2.2.1 Antioxidants (overview) 
The human body has an impressive array of defense mechanisms designed to reduce and 
control RNOS generation and repair oxidative damage (Figure 2-5). 
  
Figure 2-5: Simplified defense mechanisms against oxidative stress. 
Highlighted area indicates antioxidant defence against oxidative 
stress. (reproduced with permission 108) 
 
Antioxidants are critical to this multi-layered defense system and are capable of delaying, 
preventing or removing oxidative damage.107 Although there are multiple ways to categorize 
antioxidants, the more common system categorizes them either as enzyme (direct acting) or 
non-enzyme antioxidants (indirect acting).108 Antioxidants have specific functions, but they 
also retain some degree of redundancy and overlap, e.g. glutathione peroxidase and 
catalase. Determining which antioxidant responds first to an increase in RNOS generation 
depends initially on the type of RNOS molecule, then on the relative concentration of each 
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specific antioxidant in cytosol, plasma or tissue as well as the lipid/water solubility of the 
antioxidant. 
Enzyme antioxidants are also known as primary antioxidants, because they represent the 
first line of defense in cells and plasma. Under normal physiological conditions they interact 
directly with RNOS before they can react with lipids or proteins, preventing the generation of 
secondary and tertiary radicals.109,110 The three main antioxidant enzymes are superoxide 
dismutase (SOD), glutathione peroxidase (GPx) and catalase. This thesis focused primarily 
on the enzyme GPx but also discussion of SOD. 
2.2.2. Superoxide Dismutase (SOD) 
The function of all forms of SOD is the dismutation of the superoxide radical to hydrogen 
peroxide (equation 1).109 SOD enzymes are present in most extracellular fluids as well as 
aerobic cells within the mitochondria and cytosol. Three iso-enzyme forms of SOD exist and 
all three contain a metal ion co-factor.  
(i) Cu-Zn-SOD (SOD-1) is present in the cytosol of cells,  
(ii) Mn-SOD (SOD-2) exists exclusively in the mitochondria,  
(iii) EC-SOD (extracellular-SOD-3), this is also a Cu-Zn containing SOD and is found 
mostly in extracellular fluid and tissue interstitial spaces.111  
In excess, the superoxide radical has the ability to generate hydroxyl (via Haber-Weiss 
pathways, Figure 2-1) or peroxynitrite (through interaction with nitrite radical), therefore any 
reduction in SOD activity will result in a disproportionate increase in the generation of other 
RNOS.  
It is unclear which form of SOD is of greatest importance, studies have shown that SOD-1 
knockout mice age more rapidly and have higher levels of skeletal oxidative stress,112 while 
decreases in SOD-3 have been associated with the development of atherosclerosis.113 
More dramatically, mice lacking Mn-SOD die within 10 days of birth from cardiac 
abnormalities.114 With the exception of mitochondrial SOD the other two forms of SOD 
require copper and zinc for normal expression and activity. The copper molecule is required 
by SOD for the disproportionation of superoxide, while zinc is required to enable the correct 
folding of the SOD protein complex.115 
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2.2.3. Glutathione peroxidase (GPx). 
The glutathione peroxidases are a group of selenium dependent enzymes with antioxidant 
activity. Their primary function is to catalyse the reduction of hydrogen peroxide to water 
(Figure 2-2 equation 2) at the expense of glutathione (GSH).109,116 GSH is oxidized in this 
process, forming GS-SG, and in the presence of GR, the GS-SG is reduced back to GSH at 
the expense of NADPH (Figure 2-2 equation 3).  
There are at least 4 identified peroxidase enzymes in this family. GPx-1 is present in nearly 
all mammalian cells representing nearly 50% of total body selenium, and resides in the 
cytosol. GPx-2 lies in the gastro-intestinal tract, GPx-3 exists as the second most abundant 
selenoprotein in plasma and GPx-4 is a monomer, as opposed to a tetramer like GPx-1, -2, 
-3, which contain 4 selenium molecules at the active site of the 4 protein subunits.116,117 The 
activity of these enzymes is dependent upon appropriate levels of selenium.82,117,118 
Previous bovine and human studies report a linear relationship between selenium levels 
and GPx activity up to a selenium level of 1.14 - 1.27 µmol/L.82,119 Levels above this do not 
appear to increase GPx activity. This relationship has formed the basis of determining the 
recommended daily intake for men and women. Even though each isoenzyme of GPx 
responds at slightly different rates to reductions in selenium, plasma GPx activity has often 
been used as a surrogate marker of selenium status and vice versa.82 Reductions in GPx 
activity are also associated with increased oxidative stress.120,121 Though GPx activity may 
be a convenient indicator of oxidative stress,122 the limitations of its use cannot be ignored. 
For example, it is unclear if plasma GPx activity reliably reflects oxidative stress in 
populations with high selenium intakes.    
2.3 Selenium and Oxidative stress modulation during Cardiac Surgery 
2.3.1 Pre-operative influences. 
In many instances, patients requiring cardiac surgery and CPB have an altered oxidant-
antioxidant balance before surgery due to a combination of lifestyle choices (poor diet, 
obesity, smoking and alcohol use)123-126 and underlying non-cardiac illnesses (diabetes, 
renal disease, lung disease).3,36 The degree to which chronic oxidant-antioxidant imbalance 
prior to surgery will influence peak oxidative stress levels during CPB is not known, because 
oxidative stress and selenium are not routinely assessed prior to surgery. Chronic oxidative 
stress has been shown to reduce endogenous antioxidant capacity.127 Therefore, it is 
plausible that subsequent triggers of ROS production may overwhelm the antioxidant 
system, resulting in increased oxidative stress mediated morbidity.  
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2.3.2. Intra-operative influences 
Observational studies have demonstrated significant selenium reductions during cardiac 
surgery.13,14,29 Likely causes for this reduction include an acute phase response (due to the 
ECC-stimulated inflammatory response) that results in a redistribution of antioxidant trace 
elements (such as selenium) to tissues and away from the intravascular circulation.46 We 
theorize that the ECC circuit may also adsorb some of these trace elements, which are key 
components of the antioxidant response. Such reductions have a high degree of clinical 
importance due to their dependent and independent associations with multi-organ 
dysfunction and mortality. Studies in the critically ill suggest that selenium should be 
administered prior to injury, as giving it after injury seems to have little effect on oxidative 
injury.128 Given that the onset of injury in cardiac surgical patients is predictable (initiation of 
CPB plus removal of aortic cross clamp) the cardiac surgical patient may be the ideal 
patient to benefit from selenium supplementation. However, to understand which patients 
may potentially benefit from supplementation it is first important to know (i) background 
levels in the local healthy population, (ii) what are the clinical consequences of low selenium 
levels.  
The oxidative stress response during CPB is due to a combination of material dependent 
(exposure of blood to non-physiologic surfaces) and material independent triggers (surgical 
trauma, ischemia-reperfusion, hyperoxia).129 Blood contact with the artificial surface of the 
ECC circuit activates neutrophils, NADPH oxidase and xanthine oxidase, causing an 
increased production of RNOS.31,45 Acute increases in oxidative stress are associated with 
increased morbidity (such as post-operative atrial fibrillation (POAF), acute kidney injury 
(AKI) and acute lung injury),32,43,44 and mortality. However, while all patients exposed to 
CPB experience an inflammatory and oxidative stress response,20,45,130 not all patients 
suffer the negative effects of these responses. However, rather than requesting costly blood 
tests for pre-operative oxidative stress levels (that may not get to be analysed prior to 
surgery), it would be beneficial to categorise patients into “at risk” groups pre-operatively. 
This may be based upon known risk factors for either increased oxidative stress or 
decreased selenium, and would add value to any prospective study investigating the 
benefits of antioxidant supplementation. To our knowledge no studies have done this. 
2.3.3 Association of oxidative stress and selenium on POAF 
POAF is the most common and significant sustained arrhythmia after cardiac surgery with 
an incidence ranging from 5 - 70%.131,132 It is thought to be closely associated with the 
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oxidative stress response and inflammation,132-135 and while it can be self-limiting, there are 
numerous post-operative complications associated with AF including; hypotension and 
shock; thromboembolic events; renal failure; prolonged ICU stay136 and higher long-term 
health care costs.137,138  
The standard course of treatment for AF in general includes rate and rhythm control and/or 
anti-coagulation.131,132,139 While there is success with either modality there are also 
significant failures and risks associated with long-term pharmacotherapy and 
anticoagulation as well as inconsistency with surgical ablation.131 Contributing to the failure 
rates of pharmacotherapy and/or surgical intervention is the lack of a full understanding of 
the precise mechanisms involved in the development of POAF.134,140 Current data suggests 
that the development of POAF is multi-factorial involving both electrical and structural 
remodelling. Within this context, inflammation and oxidative stress are two key triggers 132-
135 identified as being important components in its development; (although this study will not 
be examining the role of inflammation).  
In the cardiac surgical patient, a host of pre- and intra-operative factors contribute to 
increasing oxidative stress levels. Intra-operatively the important triggers to oxidative stress 
are myocardial ischemia-reperfusion,141 inflammation,20 hyperoxia,142 PRBC transfusion57 
and blood contact with the CPB circuit.47 Levels of lipid peroxidation and protein carbonyl 
products are elevated in the myocardium, especially after ischemic reperfusion at the end of 
surgery.51 Mitochondria, NAPH oxidase and uncoupled NOS are important sources of 
oxidative species in the myocardium at this time.143 While the exact mechanism of how 
oxidative stress induces POAF has not been determined, animal and experimental studies 
indicate that there is electro-anatomical remodelling with a down-regulation of Na+ channels 
and abnormal Ca2+ cycling within the myocyte.144  
An appropriate antioxidant response balances the generation of RNOS and reduces 
oxidative stress. Patients who develop POAF have been shown to have lower plasma and 
myocardial levels of the two main antioxidants, superoxide dismutase and glutathione 
peroxidase. Both of these antioxidants rely on specific trace elements for normal activity and 
their activities can be both decreased by intra-operative reductions and increased through 
appropriate supplementation.   
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These observations suggest that strategies to minimise oxidative stress or inflammation 
may reduce the susceptibility to POAF. So far several studies have demonstrated that 
antioxidant supplementation in the forms of Vitamin C and Vitamin E were successful as 
both prophylactic and therapeutic agents to reduce the reactive products of oxygen and 
nitrogen produced during surgery. A meta-analysis by Harling et al 87 in 2011 reviewed 6 
studies (5 were randomised controlled trials (RCT)) and concluded that despite poor overall 
quality, antioxidant vitamin therapy reduced POAF (OR 0.43, 95% CI 0.21 to 0.89) and all-
cause arrhythmias (OR 0.54, 95% CI 0.29 to 0.99). Another study suggested that this effect 
might be even greater when combined with ß-blockers.90  It is worth noting that both these 
compounds are “chain breaking” antioxidants—working to stop lipid peroxidation after it has 
begun, and they do not interact with RNOS directly. Selenium on the other hand is directly 
associated with the primary antioxidant GPx which interacts directly with hydroperoxides 
Figure 2-6: Time course of substrate development, oxidative stress and surgery-
related factors in the occurrence of atrial fibrillation.  
Time course of pro-arrhythmic mechanisms is depicted in two hypothetical patients undergoing 
cardiac surgery. Both chronic as well as acute factors related to the operation on day 0 are shown. 
When the intensity of pro-arrhythmic factors reaches a certain threshold, atrial fibrillation will occur. 
Patient 1 has no relevant cardiovascular history, only hypertension (green) at the age of 57. Patient 
2 already developed hypertension (red) at a younger age, followed by diabetes (red), mitral 
regurgitation (red), and COPD (red) at an older age, respectively. Both patients have no history of 
AF and undergo on-pump coronary artery bypass grafting at the same age. However, patient 2 has 
developed an AF substrate by the time of operation due to above mentioned cardiovascular 
diseases. Acute, surgery-related factors occur in both patients: cardiopulmonary bypass (CPB, 
yellow), inflammation (CRP, purple), oxidative stress (yellow), and sympathetic activation (yellow). 
Patient 2 develops postoperative atrial fibrillation (exceeds the ‘AF threshold’), while patient 1 
remains with sinus rhythm. AF, atrial fibrillation; COPD, chronic obstructive pulmonary disease. 
(reproduced with permission 241)  
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before excessive lipid peroxidation damage occurs. With its links to GPx and thyroid 
function, selenium supplementation may provide earlier and more direct intervention to 
restore GPx activity and reduce oxidative stress.  
It is acknowledged that oxidative stress contributes to POAF, and that administration of 
antioxidants may reduce its incidence.145 However, no studies have determined: firstly if 
selenium reductions are associated with POAF and secondly if selenium supplementation 
might reduce its incidence more effectively compared to antioxidants such as vitamin E and 
C. As a first step, this thesis monitored selenium levels of cardiac surgery patients before 
and up to five days post-surgery to investigate the association between selenium levels and 
POAF as well as the association with levels of oxidative stress. 
2.4 Selenium and Oxidative stress modulation during ECMO 
ECMO is used to support cardiac (Figure 2-7 VA-ECMO) or respiratory (Figure 2-7 VV-
ECMO) function in patients where maximal conventional medicine has failed.146 
 
Figure 2-7: Schematic of the two common forms of ECMO  
ECMO patients are critically ill and the initiation of ECMO is seen as a potentially lifesaving 
intervention. However, even in 2015 the benefit of ECMO is not definitively established, as 
there is still significant morbidity and mortality associated with its use.147,148 Despite 
purported improvements in the manufacture of ECMO systems over the last 40 years, there 
is still very limited data on whether smaller, more biocompatible ECMO circuits reduce the 
inflammatory/oxidative stress response due to contact activation and whether these circuits 
adsorb less trace elements.  
(A) depicts VA-ECMO, (B) depicts VV-ECMO. Oxygenator (red) and pumphead (blue). 
(reproduced with permission 144) 
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2.4.1 Animal models of ECMO and oxidative stress 
Studies in rabbits, pigs and lambs have produced conflicting results regarding increased 
lipid peroxidation (and the possible influence of hyperoxia). Rabbits exposed to VV and VA 
ECMO demonstrated increased lipid peroxidation, which was dependent on PaO2 during 
VV-ECMO.67 Yet in contrast, investigators were unable to demonstrate significant increases 
in lipid peroxidation, despite high PaO2 levels, in a healthy lamb model.68 In a healthy 
porcine model of VV-ECMO, it was recently been demonstrated that significant increases in 
lipid peroxidation levels occur (as measured by MDA) as well as concurrent decreases in 
SOD activity.149 The only animal study to investigate oxidative stress in a clinically relevant 
model of organ injury was conducted more than 30 years ago. In this dated study it was 
demonstrated that significant increases in lipid peroxidation occurred after smoke induced 
acute lung injury.150 It is unclear how relevant this study is in the context of the modern 
ECMO circuit, which constitutes a polymethylpentene (PMP) hollow fibre oxygenator with 
small surface area of 1.8m2. This is in stark contrast to the ECMO circuits of the 1990’s 
which were silicon membrane oxygenators with large surface areas (approximately 
4.5m2).151  
2.4.1 Human studies of ECMO and oxidative stress 
To date there has only been a single human study investigating oxidative stress during 
ECMO. In a study of 16 infants supported on ECMO, lipid peroxidation levels were 
significantly lower in the survivors (n = 12) compared to the non survivors.69 Unfortunately 
that study did not detail the type of ECMO circuit used. As the study was conducted more 
than 30 years ago, the ECMO circuit was likely a silicon oxygenator with a large surface 
area.151 This large surface area would have contributed significantly to the elevated levels of 
lipid peroxides. 
There have been no studies investigating selenium modulation during ECMO. Data on the 
critically ill, documents significant reductions in selenium, especially in those with sepsis 
and/or inflammatory syndromes. The primary causes for such reductions include chronic 
deficiency in the general population, reduced nutritional intake, hemodilution, acute phase 
response and loss in body fluids.152 In fact, Sakr and colleagues have demonstrated that up 
to 92% of patients admitted to ICU with sepsis and SIRS have low levels of selenium.153 
Many studies have also demonstrated that selenium reductions in these patients continue 
despite modest supplementation.5,153 These reductions are closely associated with Acute 
Physiology and Chronic Health Evaluation (APACHE) and sequential organ failure 
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assessment (SOFA) scores, as well as increased oxidative stress; increased organ 
dysfunction and increased mortality. Some studies suggest that when selenium reductions 
fall as low as 36 µg/L there is a high degree of sensitivity and specificity to predicting ICU 
mortality.153 Understanding the separate and combined effects of critical illness and ECMO 
on oxidative stress and selenium, may well give guidance to future studies aimed at 
reducing ECMO related morbidity and mortality.  
This thesis investigated the effect of ECMO and transfusion on oxidative stress, antioxidant 
and trace element status, using a range of healthy and critically ill controls in an in vivo 
ovine model using current low-prime ECMO circuits. 
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Rationale 
Globally there is considerable variation in selenium levels in soil and food, resulting in 
differences in total plasma selenium levels in humans.17,154 The effect of this variation 
across populations is unclear, however low plasma selenium levels have been associated 
with chronic illnesses and acute complications in critically ill patients.16,155 To determine 
associations of selenium levels with morbidity in the surgical and ill population, accurate 
measurements of normal selenium levels in the healthy population of the region being 
investigated are first needed. In 2012 there was limited current information on selenium 
levels in Australia, and no information on selenium levels in Queensland. In addition, some 
patients having cardiac surgery and most patients having ECMO therapy receive a 
considerable number of blood product transfusions resulting in a temporary dilution of the 
recipient’s own blood cells and plasma proteins. While deficiency in some micronutrients 
has been observed after PRBC transfusion in paediatric156 and Beta Thalassemia Major157 
patients, no studies have investigated whether commonly used blood products are deficient 
in selenium, and thereby increasing the risk of a dilutional reduction of selenium in the 
recipient. 
To address these information gaps this study: 
  
 determined the normal variance of selenium within a healthy blood donor population.  
 assessed if there were regional differences in selenium levels across Queensland.  
 measured selenium levels in four commonly used blood products.  
 
The results from this study were initially presented as a poster at the Australian and New 
Zealand Intensive Care Society (ANZICS) annual meeting in October 2010, where it was 
awarded the “Best Medical Poster”. That poster abstract was published in Anaesthesia and 
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Intensive Care. 2010 Volume 38, Issue 6. The full results were subsequently published in 
Journal of Trace Elements in Medicine and Biology.158 
Journal requirements for our publication where to use µg/L. For this reason Chapter 3 
retains the standard S.I. unit classification. 
 
Significance 
This study determined that plasmapharesis donors had an average plasma selenium level 
of 85.6 ± 0.5 µg/L. Of those tested, 88.5% had a level below the 90 - 100 µg/L range (1.14 - 
1.27 µmol/L), a level that has previously been shown to be required for maximal GPx 
activity. Selenium levels are profoundly reduced during critical illness, especially when 
sepsis or inflammation is involved. Thus, low levels of selenium in the healthy population 
places the surgical or critically ill patient at increased risk of selenium related morbidities. 
This study also reported for the first time the selenium levels in a range of blood products. 
The extra-cellular selenium levels in clinical fresh frozen plasma (FFP) and apheresis-
derived platelets (APH-Plt) were within the Australian reference range (0.7 – 1.4 µmol/L). 
However, in packed red blood cells (PRBC) and pooled buffy coat-derived platelets (BC-
Plt), selenium levels were below the lower limit of detection of 23.7 µg/L. This new 
information indicates that the transfusion of PRBC and BC-Plt could potentially deplete the 
recipient’s selenium level, particularly in those with low body weight or those receiving 
multiple units of blood products either acutely (i.e. massive transfusion) or over many days 
such as during ECMO. Investigations into transfusion related dilution of circulating selenium 
levels were subsequently conducted in Chapter 5.  
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Plasma selenium status in a group of Australian blood donors and fresh blood 
components. 
 
Summary 
The purpose of this study was to assess plasma selenium levels in an Australian blood 
donor population, and measure extra-cellular selenium levels in fresh manufactured blood 
components. Selenium levels were measured using graphite furnace atomic absorption 
spectrometry (GF-AAS) with Zeeman background correction. The mean plasma selenium 
level in healthy plasmapheresis donors was 85.6 µg/L, and a regional difference was 
observed between donors in South East Queensland and Far North Queensland. Although 
participants had selenium levels within the normal range (55.3 - 110.5 µg/L), 88.5% had 
levels below 100 µg/L, a level that has been associated with sub-optimal activity of the 
antioxidant enzyme glutathione peroxidase (GPx). Extra-cellular selenium levels in clinical 
fresh frozen plasma (cFFP) and apheresis-derived platelets (APH-Plt) were within the 
normal range. Packed red blood cells (PRBC) and pooled buffy coat-derived platelets (BC-
Plt) had levels at the lower limit of detection, which may have clinical implications for the 
massively transfused patient. 
 
Introduction 
Selenium, a trace element essential for optimal human health, is incorporated in the form 
selenocysteine into selenoproteins.159 There are more than 30 selenoproteins functionally 
important for human health, including the antioxidant enzyme glutathione peroxidase (GPx), 
selenoprotein P, thioredoxin reductase and iodothyronine 5’-deiodinase.159  
Selenium, in the form of amino acids selenocysteine and selenomethionine, is sourced from 
the diet.160 There is significant variation in the amount of selenium present in the soil 
globally (ranging from <0.01 µg/g to > 1000 µg/g)161 and plant food, such as brazil nuts, rice 
and wheat, as well as higher chain animal products, will reflect this variation. The result 
being significant differences in total plasma selenium levels in humans.17,154 Low plasma 
selenium levels have been associated with chronic illnesses16 and acute complications in 
critically ill patients.155 Therefore, monitoring selenium levels in a country or region is 
relevant to community health and possibly the outcomes of blood transfusion.  
Donated blood is separated into fresh blood components or manufactured into at least 20 
different plasma-derived blood products.162 The concentration of various micronutrients, 
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including selenium, in fresh components depends on the level in the donor at the time of 
donation. It is plausible that large volume blood transfusions may result in depletion of 
micronutrients in the recipient to levels similar to those in the transfused component.163 The 
level of extra-cellular selenium in manufactured fresh blood components issued by the 
Australian Red Cross Blood Service (ARCBS) is currently unknown. The aim of this study 
was to measure plasma selenium levels, by graphite furnace atomic absorbance 
spectrometry (GF AAS), in an Australian plasmapharesis donor population, as well as in 
supernatant fluids from manufactured fresh blood components.   
Materials and Methods   
A total of 592 plasmapheresis donors from three regions in Queensland (Toowoomba (221), 
Rockhampton (220) and Cairns (151)) were enrolled in the study between 20 January 2010 
and 29 October 2010. Written consent was obtained from all participants and a study-
specific questionnaire (asking about history of thyroid or celiac disease, diabetes, smoking 
and multivitamin use) was completed prior to sample collection. Additional demographic 
information was obtained retrospectively from ARCBS records. This study was conducted 
under approval from the ARCBS Human Research Ethics Committee. 
Samples (6 ml) were collected from either donor whole blood (n = 592) or fresh 
manufactured blood components PRBC (n = 8), cFFP (n = 8), APH-Plt (n = 7) and BC-Plt (n 
= 3) into trace element-free tubes (Greiner Bio-One, Monroe, North Carolina, United 
States). Samples were processed and stored as per Queensland Health protocols. 
Specifically, samples were stored at 4 ◦C until cold centrifugation (4 ºC) at 3000 rpm (1683g) 
for 15 minutes. Plasma was transferred to plastic Eppendorf tubes® and transported at 4 ◦C 
to a central laboratory where plasma selenium was measured by GF-AAS with Zeeman 
background correction using a Varian AA280Z analyser (Agilent Technologies Inc, Santa 
Clara CA, United States). Internal quality controls were included with each run using 
commercial serum control material (UTAK Laboratories, Valencia, CA, U.S.A.). Inter-assay 
imprecision was 5.5%. Analysis of covariance (ANCOVA- GLIM Genstat: VSN International 
Ltd., Hemel Hempstead, United Kingdom) was performed to identify factors important in 
explaining selenium levels and also to identify interactions between significant factors.  
 
 35 
 
Results  
The mean plasma selenium level 
in study participants was 85.6 ± 
0.5 µg/L (SD,12.9; range 55.2 – 
173.7 µg/L). Selenium levels were 
within the normal reference range 
(55.0 - 110.5 µg/L) for 98% of 
participants (581/592), the 
remaining 11 participants had 
selenium levels greater than 
110.5 µg/L (0.2%). Selenium 
levels were equal to or below 100 
µg/L in 88.5% (524/592) of 
donors, while 43.4% (257/592) 
had levels below 80 µg/L.  
Predictor variables significant in 
explaining serum selenium levels 
included: region (p = 0.005), 
gender (p = 0.014), multivitamin 
use (p = 0.01) and thyroid 
medication (p = 0.02). No 
significant interaction between 
any of these factors was 
observed (p ≥ 0.35 in all 
analyses). Neither BMI, number of prior donations, smoking, diabetes nor celiac disease 
were significant predictors (p ≥ 0.33) of lower selenium levels. Mean plasma selenium 
concentrations in donors from South East Queensland (Toowoomba) were significantly 
lower than donors from Far North Queensland (Cairns) (p = 0.002) and donors from Central 
Queensland (Rockhampton) (p = 0.04). 
No significant difference (p = 0.14) between donors from Far North Queensland and Central 
Queensland was observed. The average plasma selenium level in female plasmapheresis 
donors was significantly (p = 0.01) lower than in males. The average plasma selenium 
concentration in donors taking multivitamins at the time of donation was significantly (p = 
Table 3-1: Selenium levels in Queensland 
plasmapheresis donors 
 N Average ± SD(µg/L)
Combined Total 592 85.6±0.5 
Location   
Cairns 171 87.2 ± 13.0 
Rockhampton 200 86.3 ± 9.8 
Toowoomba  # 221 83.7 ± 15.0 
Gender  #   
Male 371 86.7 ± 12.4 
Female 221 83.7 ± 13.6 
BMI category   
Underweight (<18.5) 1 94.8 
Normal (18.5 – 24.9) 140 84.6 ± 12.8 
Overweight (25 – 29.9) 267 86.2 ± 13.7 
Obese (>30) 181 85.4 ± 11.9 
Multivitamin use* #   
No 324 84.8 ± 12.4 
Yes 181 87.2 ± 13.4 
Thyroid medication* #   
No 498 85.9 ± 12.8 
Yes 8 74.0 ± 10.3 
Smoker    
No 472 85.8 ± 12.9 
Yes 35 85.3 ± 11.5 
Diabetic    
No 499 85.6 ±12.8 
Yes 8 90.8 ± 14.0 
Coeliac disease   
No 506 85.8 ± 12.8 
Yes 1 63.2 
* Indicates incomplete responses to questionnaire.  
# Indicates significant difference (p < 0.05) for values in 
category. 
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0.01) higher than in those not taking multivitamins (multivitamin brand not specified). A 
small number of donors (8/592) reported taking thyroid medication (medication not 
specified) at the time of donation. They had significantly (p = 0.02) lower average selenium 
concentrations than donors not taking thyroid medication. One donor who had a history of 
coeliac disease had serum selenium levels towards the lower end of the normal range. 
Some participants did not complete all answers in the questionnaire, however, considering 
the non-recording rate was low, we do not believe it alters validity of these observations. 
Selenium levels in PRBC and BC Plt’s were at, or below, the limit of detection by GF AAS 
analysis (<23.7 µg/L). Conversely, cFFP (71.1 µg/L, SD 7.3) and APH-Plt (92.1 µg/L, SD 
9.2) components had selenium levels that were comparable to plasma selenium levels in 
donors.   
Discussion 
Selenium is a micronutrient essential to human health and while significant global variation 
in plasma selenium levels has been reported, there are limited studies for the Australian 
population (Table 3-2).164-170 The present study assessed plasma selenium levels in donors 
from three geographically distinct regions and demonstrated that selenium levels in donors 
from South East Queensland (Toowoomba) were lower than those from Far North 
Queensland (Cairns) and Central Queensland (Rockhampton). These data, together with 
previous studies in South Australia 167,168,170 and Tasmania 164,166 (Table 3-2), highlight 
regional variation in levels of this micronutrient in the Australian population. 
Author Year Sample 
Size 
Location Selenium Level 
(µg/L, mean (SD)) 
Method 
Used 
Judson et al 168      1978 116 South Australia 152 (nr) nr 
Judson et al 167 1982 30 South Australia 143.3 (nr) Flurometric 
Dhindsa et al 165 1998 196 New South Wales 91.8 (15) ICP-MS 
Lyons et al 170 2004 288 South Australia 103 (11) ICPOES 
Jacobson et al 166 2007 335 Tasmania 110 (19) ICP-MS 
Lymbury et al 169 2008 140 Australia 100.2 (SEM 1.3) ICP-MS 
Beckett et al 164 2011 498 Tasmania 89.1 (15.1) GF-AAS 
nr- not recorded; ICP-MS, inductively coupled plasma mass spectrometry; ICPOES, inductively  
coupled plasma optical emission spectrometry; GF-AAS, graphite furnace atomic absorbance spectrometry. 
 
Table 3-2: Published selenium levels in Australia 
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The average plasma selenium level in the Queensland population studied was within the 
normal reference range currently used in Australia (55 - 110 µg/L). However, the majority of 
donors (88.5%) had levels that were below 100 µg/L and 43.4% had levels below 80 µg/L. 
Some studies report that a plasma selenium level of at least 80 - 90 µg/L is needed for 
maximal antioxidant GPx activity,171,172 while others report a level at or near 100 µg/L.159,173 
Our study demonstrated that a relatively high proportion of participants in Queensland had 
plasma selenium levels that were below a level associated with reduced GPx activity. In 
previous Australian studies, plasma selenium levels below 100 µg/L were reported for 29% 
of Tasmanians 166 and 39% of South Australians.170 In this study we demonstrate that 
88.5% of volunteer donors had plasma selenium below 100 µg/L, a considerably larger 
proportion than those previously reported. Further analysis using identical methodology and 
similar inclusion criteria are required to confirm these interstate differences. 
This study demonstrated significantly higher selenium levels in donors who reported 
multivitamin use. In Australia, the recommended daily intake of selenium is 70 µg for men 
and 60 µg for women.161 Commonly available multivitamins in Australia contain between 20-
65 µg of selenium per tablet, which, if used on a daily basis, would constitute a significant 
portion of the recommended daily intake for both males and females. While the brand of 
multivitamin used by study participants, and its selenium content was not recorded, our 
study suggests that regular multivitamin use increases plasma selenium levels. 
A novel aspect of this study was the measurement of extra-cellular selenium levels in 
manufactured fresh blood components. PRBC and BC-Plt’s had selenium levels at the lower 
limit of the detection by GF-AAS, which is to be expected given these components are 
manufactured in an additive solution (SAGM for PRBC’s and SSP+ for BC-Plt’s) rather than 
plasma. Conversely, APH-Plt and cFFP components had levels comparable to the 
plasmapheresis donor average, and within the normal range. It is currently unclear if there 
are clinical implications of transfusing selenium depleted fresh blood components. 
Deficiency in other micronutrients has been observed after significant PRBC transfusion in 
paediatric156 and Beta Thalassemia Major157 patients. In certain patient populations, 
reduced plasma selenium levels have been associated with increased morbidity and 
mortality,13,128,174 therefore it may be prudent to further assess plasma selenium levels in 
transfusion-dependent and massively transfused patients and if indicated, to consider 
supplementation. 
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Conclusion 
The results from this study add, for the Australian donor population, current and much 
needed data regarding plasma selenium levels. Studies examining the benefit of selenium 
supplementation for various diseases and illnesses have increased in the past decade. 
Further research is required to determine whether anti-oxidant pathways are compromised 
in massively transfused patients, in part as a result of lowered selenium levels, and whether 
this could be ameliorated by selenium supplementation. 
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Rationale 
During CPB there is increased production of reactive oxygen species (ROS) and reactive 
nitrogen oxide species (RNOS) due to blood contact with the ECC initiating inflammation, 
ischemia/reperfusion, hyperoxia and shear stresses.31,175 These reactive species create an 
environment of oxidative stress, which have been shown to contribute to myocardial 
depression, cardiac arrhythmias, pulmonary dysfunction and acute kidney injury.4 The 
oxidative stress response is mitigated by an appropriate antioxidant response.36 Some trace 
elements, such as selenium, copper and zinc, are critical to this antioxidant response, 
(either directly or by being an essential part of antioxidant enzymes). Selenium in particular, 
has been shown to be reduced after cardiac surgery and low levels are associated with 
poorer outcomes. This study was designed to:  
 determine if the CPB circuit is capable of adsorbing essential trace elements.  
 determine if priming the CPB circuit with albumin would mitigate the loss of trace 
elements. 
The results from this study were presented at the 27th ASM of the Australian and New 
Zealand Society of Cardiovascular Perfusionists in 2010 and awarded “Best Scientific 
Presentation”.   
 
Significance 
The findings of this study are clinically relevant as the data demonstrated for the first time 
that the CPB circuit is capable of adsorbing essential trace elements, and that simple 
measures to try an prevent this (i.e. priming CPB circuit with albumin) are ineffective. As 
reductions in essential trace elements occur after cardiac surgery and are associated with 
poor outcomes, particularly for selenium, we can now show a mechanism for losses that 
may be as high as 29% of some essential trace elements. These results will help clinicians 
and nutritionists decide whether acute reductions after surgery are real deficiencies (as 
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opposed to acute phase shifts, where levels will probably normalise over time) and therefore 
whether these patients should require, and receive supplements. 
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Antioxidant trace element reduction in an in vitro cardiopulmonary bypass circuit. 
 
Abstract  
Many complications occurring after cardiac surgery are attributed to an acute increase in 
reactive oxygen and reactive nitrogen species, which under normal conditions are 
balanced by the antioxidant response. Two key enzymes of the antioxidant response, 
glutathione peroxidase (GPx) and superoxide dismutase (SOD) rely on trace elements 
for normal function. 
It was hypothesized that circulation of blood through the cardiopulmonary bypass circuit 
(CPB) would (i) reduce trace element levels and antioxidant function (ii) increase 
oxidative stress and that (iii) pre-priming circuits with albumin would ameliorate trace 
element loss. This hypothesis was investigated by circulating fresh human whole blood in 
an in vitro CPB circuit. Plasma selenium, copper and zinc levels were measured, as were 
SOD and GPx and oxidative stress by TBARS. In spite of significant decreases in copper 
and zinc levels, SOD levels increased with time. Significant decreases in selenium were 
associated with a trend to increase TBARS but no change in GPx. Pre-priming with 
albumin provided no benefit in reducing trace elements loss nor in lowering levels of 
oxidative stress. This study confirms that CPB circuits cause significant depletion of the 
trace elements selenium, copper and zinc, which are necessary to maintain redox 
balance. The loss of trace elements is a potential contributor to cardiac surgical 
morbidities and further studies in the cardiac patient population are warranted to 
investigate this.  
  
Introduction 
Despite advances in cardiac surgery, notably from improvements in the biocompatibility 
of cardiopulmonary bypass (CPB) components, morbidity after cardiac surgery remains 
an area of great concern. During CPB there is an increased production of reactive 
oxygen species (ROS) and reactive nitrogen oxide species (RNOS) initiated by 
inflammation,20 ischemia/reperfusion,176 hyperoxia142 and shear stresses.177 These 
reactive species cause oxidative stress which contributes to myocardial depression, 
cardiac arrhythmias,178,179 pulmonary dysfunction180,181 and acute kidney injury.182 Under 
normal physiological conditions redox homeostasis is maintained by an appropriate 
antioxidant response. The antioxidant enzymes glutathione peroxidase (GPx) and 
superoxide dismutase179 are two primary antioxidants fundamental in maintaining this 
redox homeostasis,179 preventing an excessive build-up of SOD and hydrogen peroxide 
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(Figure 4-1). Their activity is dependent on appropriate levels of essential trace elements 
such as selenium for GPx activity,183 and copper and zinc for SOD activity.184,185   
 
 
Reductions of selenium in non-cardiac critically ill patients have been associated with 
increases in mortality and morbidity,5,128 while a recent study of adult cardiac surgical 
patients indicated that decreases in selenium were associated with increased post-
operative multi-organ failure (MOF).13 Hence, understanding the etiology of trace element 
reductions and their influence on oxidative stress during cardiac surgery may inform 
improvements to CPB circuits, and identify ways to reduce morbidities. This study used a 
closed loop in vitro CPB model to test the hypothesis that (i) the large surface area of the 
CPB circuit can reduce trace elements, which decreases antioxidant activity and 
increases oxidative stress; (ii) priming the CPB circuit with albumin would mitigate loss of 
trace elements. 
Materials and Methods 
Circuits 
The in vitro closed-loop CPB model consisted of a Trillium-coated Affinity NT oxygenator 
with hard shell reservoir (Medtronic Pty Ltd, Minneapolis, MN, USA), Affinity NT arterial 
filter and Trillium-coated tubing. A roller-pump (Jostra HL-20 HLM, Maquet, Germany), 
Figure 4-1: Cardiac surgery and cardiopulmonary bypass (CPB) increase 
production of reactive oxygen species like superoxide (O2). 
The antioxidant enzyme superoxide dismutase (SOD) converts superoxide to hydrogen peroxide 
(H2O2). SOD requires Cu and Zn for normal function. Glutathione peroxidase (GPx) catalyses 
conversion of H2O2 to water. GPx requires selenium for normal function. Oxidative stress and 
injury occurs when superoxide and hydrogen peroxide levels increase above capacity of SOD 
and GPx to maintain balance. 
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Jostra heater-cooler and in-line blood gas analyser (CDI500, Terumo Cardiovascular, 
Tustin, CA, USA) were used.  
Five CPB circuits (PR) were primed with one liter of crystalloid (Plasma-lyte P-148, 
Baxter Healthcare Pty Ltd, Toongabbie, NSW, Australia). This was exchanged in part for 
two units of type-matched fresh human whole blood followed by porcine mucosal heparin 
(5000 IU) (Pfizer, Pty Ltd, Perth, Australia), 30 ml sodium bicarbonate 8.4% (Pfizer, Pty 
Ltd, Perth, Australia) and 2.7 mmol calcium chloride (Phebra Ltd, Lane Cove, Australia). 
Another five circuits (AR) were primed with one liter of 4% human albumin (Albumex 4, 
CSL Ltd, Bioplasma division, Broadmeadows, Vic, Australia) and circulated for one hour 
at 36 °C. Albumin was exchanged with 2L Plasma-lyte at a rate of 50 ml/min. Blood and 
other additives were added as described for PR circuits. The blood was circulated at 
3.0 L/min, warmed (36 °C) and oxygenated (pO2 200 – 300 mmHg). To minimize the 
potential for haemolysis, roller pump head occlusion was adjusted using the standard 
static drop method.186  
Fresh human whole blood 
The Australian Red Cross Blood Service (10-01QLD-09) provided 20 units of fresh non-
leukodepleted whole blood (< 5 days old). Two units of group-matched whole blood were 
used per circuit. Both units were connected via a perfusion priming line and mixed from 
one bag to another prior to addition to the circuit. 
Blood samples 
Baseline samples were collected prior to blood being introduced to the circuit (T0) and 
from the post-oxygenator sample line at 10 min (T1) and 120 min (T2) of circulation. 
Haemoglobin levels, platelet and white blood cell counts were measured (Abbott Cell-
Dyne 3200 Multiparameter Haematology analyser. Abbott Diagnostics Division, North 
Ryde, Australia). Haemoglobin levels at T1 and T2 were compared with T0 for each 
circuit to determine the haemodilution factor.* Reported results were corrected for 
haemodilution.  
*    Addendum to publication:  
     For each circuit a dilution factor was calculated based upon the measured haematocrit of the 
combined blood bags (Hct blood bag) divided by the haematocrit at T1 and T2 (Hct time x). 
  
    Dilution factor = Hct time x /Hct blood bag 
 
       The measured value for each of the trace elements was then divided by this dilution factor. 
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Analytical methods. 
Blood was collected into trace element sodium heparin tubes (Greiner Bio-one GmbH, 
Kremsmunster, Austria), plasma separated and stored at -80 °C until analysis. Selenium 
and copper were analysed using graphite furnace atomic absorbance spectrophotometry 
(GF AAS; Varian AA280Z, Agilent Technologies Inc, Santa Clara, CA, USA); zinc was 
analysed by colorimetric assay (ABX Pentra 400, Horiba ABX Inc, Kyoto, Japan). 
Ethylenediaminetetraacetic (EDTA) plasma for oxidative stress and antioxidant analysis 
was separated and stored at -80 °C until analysis.  
Thiobarbituric acid reactive substances (TBARS) were measured using the Cayman 
TBARS assay (Cayman Chemical Company, Ann Arbor, MI, USA). Results were 
expressed as units of malondialdehyde (MDA). 
Glutathione peroxidase (GPx) activity in plasma was measured using a GPx assay kit 
(Cayman Chemical Company, Ann Arbor, MI, USA), which measures GPx activity in 
extracellular fluid indirectly by a coupled reaction with glutathione reductase (GR).  
Superoxide dismutase activity in plasma was measured using Cayman SOD assay kit 
(Cayman Chemical Company, Ann Arbor, MI, USA), which measures all three isotopes of 
SOD (SOD1, SOD2, SOD3).  
Serum albumin was measured on a Beckman DxC600 clinical chemistry analyser 
(Beckman Coulter, Inc., Brea, CA, USA). 
Statistical analysis  
Within each group of circuits, changes from baseline were assessed using a one-way 
ANOVA with Tukey post-hoc analysis (Graphpad Prism 5, version 5.0d). Using a 95% 
confidence interval (CI), results were considered statistically significant if p < 0.05. An 
independent t-test was used to identify significant differences of similar time points 
between the PR and AR circuits. Results are reported as mean ± standard deviation.  
Results 
The mean age of whole blood (n = 20) was 4.0 ± 1.0 days, and the volume added to each 
circuit was 1065 ± 1.1 ml. The minimum circulating volume of the CPB circuits was 1500 
ml. Platelet counts at T0 were comparable between the circuits (188.2 ± 23.6 x 109/L vs. 
186 ± 31.0 x 109/L, PR:AR). At T2 there were profound reductions in both circuits (92.8 ± 
19.7 x 109/L vs. 103.0 x 109/L, PR:AR). No differences existed between the PR or AR 
circuits at these time points. White blood cell counts were also comparable at T0 in both 
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circuits (4.55 x 109/L vs. 4.11 x 109/L, PR:AR), with profound reductions at T2 in both 
circuits (1.12 x 109/L vs. 1.51 x 109/L, PR:AR). No differences existed between the PR or 
AR circuits at these time points.    
 
Trace Elements 
Zinc levels were at the upper range of normal at T0 (Figure 4-2A) (PR-21.8 ± 2.5 µmol/L, 
AR-20.4 ± 2.9 µmol/L). Zinc levels in both circuits were significantly reduced at T1, but 
remained within the normal range, (PR-15.4 ± 3.5 µmol/L, AR-15.2 ± 1.6 µmol/L), 
representing a 29% reduction. There were no further reductions at T2 (PR- 15.4 ± 1.1, 
AR-15.2 ± 1.9 µmol/L). No significant differences were detected between corresponding 
time points in the PR and AR circuits.  
Figure 4-2: Plasma zinc (A), copper (B), and superoxide dismutase (SOD) (C) levels 
pre-cardiopulmonary bypass circuit (T0), at 10 min (T1) and 120 min 
(T2) of whole blood circulation. 
Copper levels were at the lower limit of the normal range for both AR and PR circuits at 
T0 (Figure 4-2B). Mean copper levels were reduced by 18.2% at T1 in the PR circuits 
Circuits were preprimed with Plasma-lyte (PR, n = 5, white) or Albumin (AR, n = 5, grey). Normal 
reference ranges for copper and zinc are indicated by grey background box. Significant 
differences (p < 0.05) with respect to T0 are marked with asterisks. Infinity () indicates a 
significant difference with respect to T1. 
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(13.2 ± 0.8 µmol/L (T0) to 10.8 ± 1.1 µmol/L (T1)), remaining unchanged at T2 (10.8 ± 1.1 
µmol/L). In the AR circuits there was a reduction of 17.6% at T1 (13.6 ± 2.2 µmol/L (T0) 
to 11.2 ± 1.8 µmol/L (T1)). Levels at T2 rose marginally (12 ± 1.6 µmol/L). Although this 
was an 11.7% reduction, it was not statistically significant. Levels at T1 and T2 in the PR 
circuits were below the lower limit for normal. No significant differences were detected 
between corresponding time points in the PR and AR circuits. 
The level of selenium at baseline (T0) was 0.82 ± 0.11 µmol/L for both circuits (Figure 
4-3A). Levels declined equally in both the PR and AR circuits at T1 (0.68 ± 0.08 µmol/L), 
representing a 17.1% reduction. Selenium levels were similarly reduced in both circuit 
groups at T2 (PR- 0.68 ± 0.08 µmol/L. AR- 0.68 ± 0.04 µmol/L). Mean levels at T1 and T2 
were just below the lower limit of the defined normal range of 0.7 - 1.4 µmol/L. No 
significant differences were detected between the PR and AR circuits at corresponding 
time points. 
 
 
Superoxide dismutase levels 
There was a significant increase in SOD activity in the AR circuits at T1 compared to T0 
(2.13 ± 0.61 to 3.04 ± 0.57 U/ml) but levels in the PR circuits decreased (3.34 ± 1.35 to 
2.67 ± 0.86 U/ml), (Figure 4-2). At T2 there was a significant increase in activity in the 
PR circuits with respect to T1 (2.67 ± 0.86 to 4.60 ± 1.72 U/ml) but not when compared to 
Figure 4-3: Selenium levels (A) and glutathione peroxidase (GPx) activity (B) 
Selenium levels (A) and glutathione peroxidase (GPx) activity (B) precardiopulmonary bypass 
circuit (T0), at 10 min (T1) and 120 min (T2) of whole blood circulation. Circuits were preprimed 
with Plasma-lyte (PR, n = 5, white) or Albumin (AR, n = 5, grey). Normal selenium reference 
range is indicated by grey background box. Significant differences (p < 0.05) with respect to T0 
are marked with asterisks.
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T0 (3.34 ± 1.35 U/ml). In the AR circuits SOD activity at T2 (4.42 ± 0.25 U/ml) was 
significantly increased when compared to T1 and T2. No significant differences were 
detected between the PR and AR circuits at corresponding time points. 
 
Glutathione Peroxidase (GPx) activity. 
GPx activity did not increase significantly at T1 (p > 0.05) (Figure 4-3B) in either the PR 
or AR circuits (25.12 ± 8.30 nmol/min/ml, 30.91 ± 3.55 nmol/min/ml), or at T2 (27.81 ± 
5.96 nmol/min/ml, 29.98 ± 5.58 nmol/min/ml). However, there were no significant 
differences between the PR and AR circuits at any of the same time points. 
Thiobarbituric Acid Reactive Substances (TBARS) activity. 
No difference was detected between the PR and AR circuits at the same time points 
(Figure 4-4). There was a trend towards an increase from T0 to T1 (PR- 2.19 ± 0.60 to 
2.75 ± 0.78 µM, AR- 2.11 ± 0.75 to 3.14 ± 0.79 µM), and also at T2 (3.48 ± 1.05 µM, 3.49 
± 1.81 µM. PR and AR respectively) but these increases did not prove to be statistically 
significant. 
 
 
 
Figure 4-4: Thiobarbituric reactive substances (TBARS) activity 
Thiobarbituric reactive substances (TBARS) activity in plasma precardiopulmonary bypass 
circuit (T0) and at 10 min (T1) and 120 min (T2) of whole blood circulation. Circuits were 
preprimed with Plasma-lyte (PR, n = 5, white) or Albumin (AR, n = 5, grey). MDA, 
malondialdehyde. 
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Albumin 
In the PR circuits, albumin levels fell significantly by 19.5% from 33.8 ± 0.8 g/L at T0 to 
27.2 ± 1.6 g/L at T1 (Figure 4-5) and remained unchanged at T2 (27.4 ± 1.5 g/L). In the 
AR circuits there were also significant reductions (15.7%) in serum albumin from 34.2 ± 
2.5 g/L (T0) to 28.8 ± 3.8 g/L (T1). Mean levels at T2 were 30.0 ± 2.0 g/L, which was also 
a significant reduction. There were no differences between the two circuits at similar time 
points. 
 
Discussion 
Profound reductions of key trace elements have been shown to occur after CPB,13 
however, the reasons for these reductions are unclear. Results from this study confirm 
that significant quantities of trace elements; copper, zinc and selenium are lost when 
whole blood is exposed to the CPB circuit. 
There was a rapid and significant reduction of copper, zinc and selenium in whole blood 
contact with CPB circuit, irrespective of whether the circuits were pre-primed with 
plasma-lyte or albumin. Plasma levels of copper were reduced from pre-circuit baseline 
levels by 18.2%, zinc by 29% and selenium by 17.1%, mirroring results from another 
clinical study.13 These reductions have compelling clinical implications, as CPB is one of 
the major triggers for an increased production of ROS/RNOS, which causes oxidative 
stress and contributes significantly to post-operative mortality and morbidity.179,187  
Figure 4-5: Albumin levels in serum 
Albumin levels in serum precardiopulmonary bypass circuit (T0) and at 10 min (T1) and 120 
min (T2) of whole blood circulation. Circuits were preprimed with Plasma-lyte (PR, n = 5, white) 
or Albumin (AR, n = 5, grey). Asterisk (*) indicates a significance difference (p < 0.05) with 
respect to T0. 
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Copper, zinc and selenium are critical to the activity of several key antioxidant enzymes 
(SOD and GPx) that help maintain redox homeostasis (Figure 4-1). Oxidative stress 
during cardiac surgery is triggered by multiple events, (inflammation,20 
ischemia/reperfusion,176 hyperoxia142 and shear stresses177), which then contributes to 
the development of post-operative morbidities. To determine if reductions in copper, zinc 
or selenium might contribute to the increase in oxidative stress, we measured TBARS, as 
well as the activity of the antioxidant enzymes GPx and SOD.  
As copper and zinc levels can determine SOD levels,185 we hypothesized reductions in 
copper and zinc associated with CPB would result in a reduction of SOD activity. Despite 
significant reductions in copper and zinc we demonstrated a transient marginal reduction 
in SOD at T1 in the PR circuits but increased SOD in the AR circuits (Figure 4-2C). At T2 
SOD levels in both circuits had increased significantly from T1 and were comparable. 
SOD exists in three distinct forms– SOD1 (cytosol), SOD2 (mitochondria) and SOD3 
(extracellular) and the assay used in our study measured all three forms. Given the rapid 
rise in SOD activity at T2, we propose that some of this increase may be due to 
mitochondrial SOD (SOD2) originating from disrupted platelets and white blood cells. 
Previous studies have shown that both roller and centrifugal pumps used in CPB can 
damage platelets 188 and white blood cells.189 These results can be supported in our 
study by profound reductions of platelet and white blood cell counts at T2. Therefore, 
while CPB caused decreases in circulating copper and zinc levels, this did not curb the 
net SOD response, probably due to increased availability of mitochondrial SOD from cell 
damage. 
Published literature suggests that a reduction in selenium levels has clinical implications. 
A study of critically ill patients has shown that selenium levels below 0.7 µmol/L were 
independently associated with a three fold increase in morbidity and mortality.5 Recently 
low levels of selenium after cardiac surgery have also been found to be an independent 
predictor of MOF.13 The average selenium level in the WB units used prior to contact with 
the circuit was 0.82 ± 0.11 µmol/L, and 10 minutes after contact with the CPB circuit 
selenium levels in both the PR and AR circuits were 0.68 ± 0.08 µmol/L. This loss of 
selenium has clinical implications, as an equivalent reduction in a cardiac surgical patient 
would place their selenium levels at levels previously associated with increases in 
mortality and morbidity.5  
Selenium is key to GPx activity, but variations in selenium levels delay the definition and 
international reference ranges for GPx.190 Some studies report that a minimum plasma 
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selenium level of 1.13 µmol/L is needed for maximal expression of GPx activity.191 In this 
study, the additional 17% loss in selenium due to the circuit did not change the measured 
GPx activity. This reflects a limitation of this study, because the baseline whole blood 
selenium level (0.82 ± 0.11 µmol/L) was already on the lower end of the normal range. 
Hence, the GPx activity was correspondingly low. Because GPx activity was already 
reduced, further decreases in selenium caused no significant change in activity. Had 
selenium levels and GPx activity been optimal at the start (baseline), the subsequent 
17% selenium loss may have produced a detectable decrease in GPx activity.  
As the three trace elements studied are antioxidant trace elements,192 their reduction 
would be expected to increase oxidative stress. To measure oxidative stress in our 
circuits we used the TBARS assay, which assesses lipid peroxidation. Although not 
statistically significant, there was a trend to increased levels of TBARS above baseline at 
T1 and T2 in both PR and AR circuits suggesting an increase in oxidative stress (Figure 
4-4). It is possible that statistical significance may have been reached had more circuits 
been done, but availability of fresh whole blood prevented us from running more circuits. 
This is a limitation of this study. The suggestion of an increase in oxidative stress due to 
the CPB circuit is worthy of further investigation.  
The binding of whole blood proteins to the surface of uncoated CPB circuits has been 
demonstrated previously.193,194 Based on these earlier studies, it is still common practice 
that CPB circuits are primed with albumin, believing it will bind to the circuit and reduce 
the binding of other physiologically important proteins such as fibrinogen, and preserving 
platelet function.193,194 Despite albumin priming of one group (AR), we reported similar 
reductions in circulating albumin from the whole blood in both the PR and AR circuits at 
T1 and T2. Our circuits were Trillium coated, and studies have shown minimized protein 
binding with this surface coating.195 Low binding avidity of albumin may have reduced 
any benefit of albumin priming and contributed to both groups showing equal reductions 
in albumin after the addition of blood. A comparison with non-coated circuits may have 
produced a different result, as might a comparison between the various brands of surface 
coatings and CPB oxygenator types. 
Findings from this study show that albumin priming does not reduce trace element loss in 
CPB circuits. However, it is important to keep in mind that although albumin is an 
important transport protein for trace elements, other important transport proteins such as 
ceruloplasmin,196 selenoprotein-P,183 and GPx-3183 may still bind to the circuit in 
significant quantities. Thus, there are other avenues where trace elements may be lost to 
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the circuit. The contribution of these other proteins to trace element loss and their impact 
on CPB patient morbidity remain to be investigated.   
 
Conclusion  
In this in vitro CPB model there was a trend to increased oxidative stress levels, consistent 
with previous studies that show an acute increase in oxidative stress occurring during 
cardiac surgery as a result of ROS/RNOS generation. Redox homeostasis only occurs if 
there is an adequate antioxidant response, a response somewhat dependent on appropriate 
levels of trace elements. This study confirms that CPB circuits deplete circulating levels of 
antioxidant trace elements copper, zinc and selenium. Priming of circuits with albumin did 
not reduce trace element loss. These results imply that CPB patients with low selenium 
levels may have increased vulnerability to oxidative stress. 
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Rationale 
While much evidence demonstrates that the transfusion of packed red blood cells (PRBC) is 
associated with increased morbidity and mortality in some patient groups,197,198 the 
mechanisms by which this occurs after transfusion remain elusive. A limited number of 
studies indicate an increased oxidative stress response following transfusion, especially in 
neonates.56,57,199 Prolonged oxidative stress results in tissue injury and organ failure leading 
us to speculate that this might be one mechanism for the morbidity associated with PRBC 
transfusion. The primary aim of this study was to  
 investigate if transfusion of aged PRBC might invoke a greater oxidative stress 
response compared to fresh PRBC.  
Having previously determined that PRBC products have very little extracellular selenium 
(Chapter 3) we also investigated if  
 transfusion of a selenium poor blood product results in a reduction of selenium in the 
recipient 
We also measured GPx activity, copper, zinc levels and SOD activity in an in vivo ovine 
model of transfusion. Preliminary results from this study were published in abstract form in 
Vox Sanguis, 2011; 101 (suppl. 2):122. The results from this study were presented at the 
28th ASM of the Australian and New Zealand Society of Cardiovascular Perfusionists in 
2011, where it was awarded the “Encouragement award for Scientific Development”.  
 
Significance 
Transfusion of PRBC are used for the management of anaemia in both acute, (the critically 
ill, neonates, paediatrics and the elderly having major surgery), and chronic settings (e.g. 
cancer, ß-thalassemia). Though PRBC transfusion often benefits the recipient, they are not 
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risk free, and have been associated with patient morbidity and mortality. Some data also 
suggests that the age of the PRBC product may contribute to these adverse outcomes. The 
results from this study confirm that transfusion with a trace element poor blood product, 
such as PRBC, resulted in a dilutional decrease in the recipient’s trace element levels 
(especially selenium). We also demonstrated that there was an increase in oxidative stress 
after transfusion, and that there were no differences between fresh and aged PRBC. These 
results have yet to be replicated in human studies.  
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Transfusion of packed red blood cells reduces selenium levels and increases lipid 
peroxidation in an in vivo ovine model 
 
Abstract:  
Background: Oxidative stress from surgery or critical illness has been shown to adversely 
contribute to morbidity and mortality. As the stored PRBC ages, products of oxidative stress 
accumulate; recent studies also record that oxidative stress is heightened following packed 
red blood cell (PRBC) transfusions, and there are no studies that investigate if transfusion of 
aged PRBC actually increases the recipient’s oxidative stress profile more than fresh PRBC.  
Objective: To compare the effect of fresh versus aged PRBC transfusions on the recipient’s 
oxidative stress using an ovine model.  
Methods and Materials: Male sheep were transfused with either fresh (n = 6) or aged (n = 
6) ovine PRBC, and serial blood samples taken. Plasma samples were analysed for lipid 
peroxidation using the thiobarbituric acid reactive substances (TBARS) assay. This served 
as an indicator of oxidative injury. Antioxidant function and trace elements levels were also 
measured.  
Results: Like human PRBC the ovine PRBC had negligible selenium levels. Irrespective of 
age, PRBC transfusions were associated with reduced selenium levels and antioxidant 
function, which correlated with increased markers of lipid peroxidation.   
Conclusion: Transfusion of selenium poor PRBC can dilute recipient plasma selenium 
levels and compromise glutathione peroxidase antioxidant activity and thereby allowing lipid 
peroxidation. As there was no evidence that aged PRBC induced more severe oxidative 
injury, this suggests that selenium dilution is a key underlying mechanism. Further studies 
are needed to assess the impact of transfusion related oxidative stress in massive 
transfusions.  
 
Key words: oxidative stress, transfusion, glutathione peroxidase, selenium. 
 
Introduction 
The transfusion of packed red blood cells (PRBC) has been associated with increased 
morbidity and mortality.200,201 Several clinical studies have documented increased oxidative 
damage to both lipids and proteins following PRBC transfusions.56,57,199 Antioxidants are 
required to neutralize and control levels of oxygen free radicals before they exert damage. 
Glutathione peroxidase (GPx) is a primary antioxidant enzyme present in the plasma, and in 
both the cytosol and membrane of erythrocytes. There is evidence that the antioxidant 
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function of PRBC, particularly GPx, is reduced over time.202,203 GPx function is dependent 
on the trace element selenium82 and our studies show that PRBC have very low 
extracellular selenium.158 Hence transfusion of PRBC could dilute selenium levels, reduce 
GPx activity and consequently promote oxidative injury. Thus we hypothesized that aged 
PRBC would induce more oxidative injury compared to fresh PRBC, and investigated this in 
an in vivo ovine model.  
 
Material and Methods 
Study approval was granted by the Animal Research Ethics Committees of the Queensland 
University of Technology and University of Queensland. Healthy 1–3 year old male sheep (n 
= 12) with an average (± SD) weight of 40.2 ± 2.9 kg were fasted overnight, anaesthetised 
and intubated. Ovine normothermia (39 ºC) was maintained, with continuous hemodynamic 
monitoring and regular blood gas analysis (ABL825 blood gas analyser, Radiometer, 
Copenhagen, Denmark). 
 
Sheep were initially haemorrhaged 30% of estimated blood volume into Leukotrap whole 
blood (WB) bags (Pall Medical, UK). After leukodepletion, the blood was centrifuged and the 
plasma removed. Saline-adenine-glucose-mannitol (SAGM) was added and the units were 
stored at 4oC till required. Ovine PRBC (ovPRBC) compatibility with recipient sheep was 
confirmed prior to transfusion as previously described.204 Sheep were kept hypovolemic for 
thirty minutes after haemorrhage, and then transfused with two units of compatible fresh 
(less than 7 day old (do); n = 6 sheep) or aged (30 - 42 (do); n = 6 sheep) ovPRBC, 
followed by human albumin 4% (CSL inc, Broadmeadows, Vic, Australia) to replace the 
remaining haemorrhage volume. Physiological monitoring continued for four hours followed 
by euthanasia (pentobarbitone-15ml of 325 mg/ml).  
 
Blood samples were collected prior to anaesthesia (B), post-haemorrhage (H), Four hours 
after fresh (TF) or aged (TA) transfusions and from ovPRBC bags (trace element analysis 
only). Blood was collected in trace element-free tubes (Greiner Bio-One, Monroe, North 
Carolina, United States) for selenium, copper and zinc analysis, and EDTA tubes for 
thiobarbituric acid reactive substances (TBARS), GPx and superoxide dismutase (SOD) 
analysis. Samples were immediately cold centrifuged at 4 ºC and the separated plasma 
stored at -80 ºC until analysis. TBARS, GPx and SOD were analysed in plasma using 
spectrophotometric assays (Cayman Chemical Company, Ann Arbor, MI, USA). The 
TBARS assay measures malondialdehyde (MDA- an end product of lipid peroxidation) 
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which is a widely used measure of oxidative stress.205 The MDA in a sample reacts with the 
thiobarbituric acid in the TBARS assay at high temperature (90 - 100 oC) to yield a 
fluorescent product detectable at 530nm using a colorimetric assay with the result 
expressed in units of MDA. The GPx assay measured GPx activity indirectly through a 
coupled reaction with glutathione reductase (GR). The SOD assay utilized a tetrazolium salt 
to measure all three isotopes of SOD (SOD1, SOD2, SOD3). Plasma selenium and copper 
were measured by graphite furnace atomic absorption spectrometry with Zeeman 
background correction (GF-AAS) using a Varian AA280Z analyser (Agilent Technologies 
Inc, Santa Clara CA, United States). Plasma zinc was measured by colorimetric assay (ABX 
Pentra 400, Horiba ABX Inc, Kyoto, Japan).  
 
Statistical analysis 
Data was analysed using one-way analysis of variance (ANOVA) with Dunnett’s multiple 
comparisons test (Graphpad Prism 5, version 6.0a, San Diego, CA, USA). Statistical 
significance was p < 0.05 using a 95% confidence interval. Data reported (table 1) as mean 
± standard deviation. Box-whisker plots (Fig. 1) show minimum and maximum values, box is 
25th and 75th percentiles with median. 
 
Results 
Sheep were haemorrhaged a total of 881.1 ± 52.0 ml. The mean age and volume of 
transfused fresh ovPRBC was three days (2 - 7 days) and 422.5 ± 40.1 ml, and 37 days (33 
- 42 days) and 403.2 ± 52 ml for aged ovPRBC. Mean volume of albumin infused was 468 ± 
42 ml in all sheep. Haemorrhage induced reductions in MAP, CI and SVO2, which recovered 
immediately following transfusion resuscitation (Table 5-1). 
Prior to transfusion the sheep had normal whole blood levels of selenium, copper and zinc. 
In contrast, these levels were all at the lower limit of detection in the ovPRBC product 
(Table 5-1). Haemorrhage induced no significant changes to TBARS, GPx, or selenium 
levels (Figure 5-1 A-C). Transfusion of both fresh and aged ovPRBC induced similar 
increases in TBARS levels (Figure 5-1A, p < 0.05), while selenium levels decreased (p < 
0.05) with a corresponding decrease in GPx activity (Figure 5-1B and C, p < 0.05). There 
were no significant changes in SOD activity after either fresh or aged ovPRBC transfusions 
(Figure 5-1D). Compared to baseline and post-haemorrhage, zinc levels were significantly 
reduced in both the fresh and aged ovPRBC transfusion groups, (p < 0.05, Figure 5-1E), 
but no difference was detected between fresh or aged levels. Copper levels were 
significantly reduced compared to baseline levels after both fresh and aged transfusion, (p < 
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0.05), but only the aged ovPRBC transfusions post-haemorrhage levels were significantly 
reduced, (p < 0.05, Figure 5-1F). 
 
 Baseline         
(n = 12) 
Post-Haemorrhage 
(n = 12) 
Post-Fresh ovPRBC 
(n = 6) 
Post-Aged 
ovPRBC 
(n = 6) 
Hb (g/L)   80.6 ± 12.2   83.6 ± 12.6  83.0 ± 12.6  78.8 ± 12.6 
Lactate (mmol/L)   0.85 ± 0.33   1.06 ± 0.39  0.40 ± 0.06  0.38 ± 0.15 
pH   7.43 ± 0.03   7.46 ± 0.04  7.46 ± 0.04  7.45 ± 0.02 
MAP (mmHg) 104 ± 10   35 ± 9 *  82 ± 14  90 ± 13 
HR 132 ± 23 133 ± 18 113 ± 21 118 ± 20 
CI (L/min)   4.9 ± 1.7     2.0 ± 0.5 *   3.9 ± 1.4   4.6 ± 1.2 
SVO2 (%) 77 ± 8    56 ± 14 * 76 ± 8   73 ± 13 
Trace Element 
content 
Whole blood at donation          Fresh ovPRBC Aged ovPRBC 
Selenium (µmol/L) 1.35 ± 0.29 0.22 ± 0.13 * 0.15 ± 0.12 * 
Copper (µmol/L) 17.4 ± 3.3   3.0 ± 2.4 *   2.8 ± 1.6 * 
Zinc (µmol/L) 11.8 ± 1.9 24.7 ± 2.3 * 26.3 ± 5.7 * 
 
 
Discussion 
Oxidative stress and injury are terms used to describe the deleterious effect of free radicals 
on lipids, proteins and DNA. This mechanism of injury is clinically relevant especially in the 
critically ill.3,206 While there have been reports of transfusion related oxidative stress,56,57,199 
it is unclear if the age of the transfused PRBC determines the severity of oxidative injury. An 
ovine model was employed to address this question, as ovine RBC have a similar survival 
time (114 - 120 days) to human RBC,207 and ovPRBC, like human PRBC are selenium 
deplete.158 The findings from this study show that PRBC transfusions following controlled 
haemorrhage resulted in reduced selenium and an increase in lipid peroxidation. However, 
age of the PRBC transfused had no influence on either selenium or lipid peroxidation levels.  
Table 5-1: Physiologic data of sheep and trace element content of transfused 
ovPRBC 
Hb, haemoglobin; HR, heart rate; MAP, mean arterial pressure; CI, cardiac index; SVO2; mixed 
venous saturation. Physiologic data from sheep at baseline, post-haemorrhage and 4 h post-
transfusion with fresh and aged ovPRBC. Trace element levels in ovPRBC are reported and 
compared to levels in whole blood prior to processing. Data is mean ± standard deviation. 
Statistical comparisons made between groups using t-test. Asterisk (*) indicates statistically 
significant change compared to baseline data (p < 0.05).  
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To achieve redox control, antioxidants counteract the effects of oxygen and nitrogen free 
radicals. Consequently, any loss of antioxidant function produces an environment conducive 
to oxidative stress/injury. Three of the most important antioxidants in humans are GPx, SOD 
and catalase.3 GPx exists in several forms with GPx-1 occurring in the erythrocyte cytosol 
and membrane, and GPx-3 is present in extracellular fluid such as plasma.208 The function 
of GPx is exclusively reliant on the trace element selenium,82 while SOD relies on copper 
and zinc for its function.209 In this controlled ovine haemorrhage and transfusion model, we 
demonstrated that the transfusion of as little as two units of ovPRBC caused a net reduction 
in circulating levels of all three trace elements in the recipient.  
Despite reductions in plasma copper after transfusion, no reduction in SOD activity was 
detected (Figure 5-1D). Two forms of the SOD enzyme (SOD1 and SOD3) require zinc and 
copper for antioxidant activity, even though copper appears more important.209 Because 
unbound copper in cells is toxic, it is bound and transported by the copper chaperone for 
SOD.210 Therefore, we speculate that copper from this reservoir maintained the observed 
SOD activity.   
Previous studies have shown that human PRBC have negligible levels of selenium158 and 
ovPRBC demonstrated similar low levels irrespective of the age of the product (Table 5-1). 
Figure 5-1: TBARS, GPx activity, Selenium, SOD activity, Zinc, Copper in sheep 
TBARS (a), GPx activity (b), Selenium (c), SOD activity (d), Zinc (e), Copper (f) in sheep at 
baseline (B), after haemorrhage (H) and 4 h after transfusion with fresh ovPRBC (TA, n = 6) or 
aged ovPRBC (TF, n = 6). *-significant difference (p < 0.05) with respect to baseline, ψ-
significant difference (p < 0.05) with respect to haemorrhage. 
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Given that GPx function is dependent on selenium,82 we propose that the observed 
reduction in GPx function in the transfused sheep (Figure 5-1B) was a result of selenium 
dilution. Firstly, the haemorrhage would have caused a net selenium loss. The subsequent 
resuscitation to replacement volume with two units of selenium poor ovPRBC and human 
albumin 4% would then have diluted the recipient’s remaining selenium ration, which in turn 
compromised the antioxidant function of GPx. The consequence of the diminished 
antioxidant function is reflected by the increase in lipid peroxidation (as measured in the 
TBARS assay). Using albumin for volume replacement is a limitation of the study, as 
albumin itself has significant antioxidant properties.211 Hence, it is possible that the increase 
in lipid peroxidation may have been greater if a different colloid was used.  
Studies have reported that the antioxidant function of the PRBC product, particularly GPx, is 
reduced as storage time increases.202,203 Therefore, we considered it useful to determine if 
aged PRBC was associated with more severe oxidative injury than fresh PRBC transfusion. 
Serial measurements of aging human PRBC document a direct correlation of MDA and 
haemoglobin oxidation with RBC membrane damage.212 Other studies have demonstrated 
that as PRBC age there is a progressive increase of protein carbonyl and lipid peroxidation 
products which compromise function.212-215 However, in this ovine model there was no 
evidence for increased lipid peroxidation with aged PRBC transfusion adding support to the 
selenium dilution mechanism. 
Some attempts have been made to counteract PRBC transfusion related oxidative stress. A 
small study indicated that pre-donation supplementation with selenium, beta-carotene, 
vitamin C or E reduced lipid peroxidation in stored PRBC.216 Alternatively, the addition of 
antioxidant compounds, such as glutathione, to the PRBC product after donation has been 
shown to reduce oxidative damage to the red cell.217 Selenium supplementation has been 
shown to increase GPx activity,82 and supplementing critically ill patients with selenium has 
resulted in reduced mortality.80 However, no studies have investigated this effect solely after 
transfusion. While further data is needed, selenium supplementation may provide a 
potentially safe and economical intervention to increase GPx function and improve redox 
control especially in cases of massive transfusion. Animal models may provide the means 
for investigating the effect of antioxidant supplementation on oxidative stress levels 
following massive transfusion. 
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Rationale 
While ECMO is commonly used for the treatment of acute respiratory distress syndrome 
(ARDS) that is refractory to conventional medicine, the morbidity and mortality rate in this 
cohort is still high.218 It is unclear from the literature whether the morbidity and mortality 
associated with this intervention is a result of overwhelming aspects of the underlying illness 
or if the ECMO circuit significantly contributes by some, as yet, undefined mechanism. 
While limited animal studies have demonstrated an increase in oxidative stress when 
ECMO is used in healthy animals,67-69,150 many of these studies have used ECMO circuits 
that are no longer available, thus questioning the relevance of the “old” published data to 
today’s practice. Additionally, given that low selenium levels in the critically ill patient, 
independent of oxidative stress, are associated with adverse outcomes,128 it is plausible that 
ECMO might also be associated with significant reductions in selenium and thus contribute 
to ECMO related complications and adverse outcomes. Therefore, the primary aims of this 
study were to investigate in an in vivo ovine model:  
 the effect of an acute lung injury on oxidative stress, antioxidant and selenium status, 
 the additional effect of ECMO and transfusion on oxidative stress, antioxidant and 
selenium status using a range of healthy and critically ill controls.  
The results of this study were initially presented at the 29th ASM of the Australian and New 
Zealand Society of Cardiovascular Perfusionists in 2012 where it was awarded the “Best 
Scientific Presentation”. This study was also presented at The Prince Charles Hospital 
Research Forum in 2014 where it won the “Michael Ray Best Basic/Translational Research 
Project.”  
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Significance 
As the therapeutic role of ECMO is expanding across various areas of critical illness, the 
need to understand the acute and chronic interactions between patient and ECMO circuit is 
never more present. For the first time, we have demonstrated that the combination of acute 
injury and ECMO results in significant disturbances to selenium compared to either 
intervention alone. However, as far as oxidative stress is concerned, the addition of ECMO 
did not result in a greater oxidative stress response compared to the response associated 
with acute injury. We were unable to determine any effect on either parameter as a result of 
transfusion, but this may be due to the small transfusion volume. As this was in an ovine 
model, clinical studies are needed to confirm if ECMO patients experience similar effects. 
Patients often remain on ECMO support for weeks to months, and the longer term effects of 
this intervention remains to be investigated. In addition the influence of selenium on 
immune, inflammatory and thyroid function open many more avenues of investigation in this 
patient population. 
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The impact of Acute Lung Injury, ECMO and transfusion on oxidative stress and 
plasma selenium levels in an ovine model. 
 
Abstract: 
The purpose of this study was to determine the effects of smoke induced acute lung injury 
(S-ALI), extracorporeal membrane oxygenation (ECMO) and transfusion on oxidative stress 
and plasma selenium levels. Forty ewes were divided into (i) healthy control (n = 4), (ii) S-
ALI control (n = 7), (iii) ECMO control (n = 7) (iv) S-ALI + ECMO (n = 8) and (v) S-ALI + 
ECMO + packed red blood cell (PRBC) transfusion (n = 14). Plasma thiobarbituric acid 
reactive substances (TBARS), selenium and glutathione peroxidase (GPx) activity were 
analysed at baseline, after smoke injury (or sham) and 0.25, 1, 2, 6, 7, 12 and 24 hours 
after initiation of ECMO. Peak TBARS levels were similar across all groups. Plasma 
selenium decreased by 54% in S-ALI sheep (1.36 ± 0.20 to 0.63 ± 0.27 µmol/L, p < 0.0001), 
and 72% in sheep with S-ALI + ECMO at 24hr (1.36 ± 0.20 to 0.38 ± 0.19, p < 0.0001). 
PRBC transfusion had no effect on TBARS, selenium levels or glutathione peroxidase 
activity in plasma. While ECMO independently increased TBARS in healthy sheep to levels, 
which were similar to the S-ALI control. The addition of ECMO after S-ALI caused a 
negligible increase in TBARS. This suggests that the initial lung injury was the predominant 
feature in the TBARS response. In contrast, the addition of ECMO in S-ALI sheep 
exacerbated reductions in plasma selenium beyond that of S-ALI or ECMO alone. Clinical 
studies are needed to confirm the extent and duration of selenium loss associated with 
ECMO. 
Introduction  
Patients with acute respiratory distress syndrome (ARDS) are critically ill and exhibit 
increased oxidative stress and reduced selenium levels compared to other hospital in-
patients.219,220 Regardless of the cause of lung injury, oxidative stress is thought to be a 
major contributor to the pathogenesis and progression of ARDS.44,219 The mortality among 
patients with acute lung injury (ALI) and ARDS may be as high as 41%, and in severe cases 
of ARDS, veno-venous extracorporeal membrane oxygenation (VV-ECMO) provides a 
rescue therapy for temporary respiratory support.218,221  
VV-ECMO involves the insertion of large cannulae into the central venous circulation, 
redirecting the blood through an oxygenator (artificial lung), where carbon dioxide is 
removed and oxygen is added. (Figure 6-1) Oxygenated blood is then returned through a 
cannula to the right side of the heart before passing through the lungs. ECMO circuits have 
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a large surface area to enable efficient gaseous exchange, however exposure of the 
patient’s blood to these foreign surfaces initiates an inflammatory response222 as well as 
adsorbing trace elements and drugs.47,223  
 
Figure 6-1: Schematic diagram of sheep on VV-ECMO.  
ECMO cannulae are inserted via right internal jugular vein (RIJV). 
 
Oxidative stress occurs when excessive production of reactive species of oxygen (ROS) 
overwhelms the antioxidant system.36 Excessive ROS production during sepsis, systemic 
inflammation and/or ischemia-reperfusion injury has been associated with cellular, tissue 
and ultimately organ injury.36 Additionally, extracorporeal circuits (ECMO, dialysis, CPB) 
involve extensive blood contact with a foreign surface, and this coupled with hyperoxia and 
massive blood transfusions have the potential to augment oxidative stress.77,224 Whether 
oxidative stress in this setting contributes to the morbidity/mortality risk of patients on ECMO 
is unclear. 
Selenium is a trace element incorporated into a variety of selenoproteins involved in 
antioxidant, thyroid, immunological and inflammatory regulation.225 While some studies have 
demonstrated a negative correlation between selenium and oxidative stress,120,226 reduced 
plasma selenium levels have also been independently associated with worse outcomes in 
some critically ill patients.153 Glutathione peroxidase (GPx), a primary antioxidant enzyme, 
requires selenium for normal functioning.84 The reduction of serum selenium levels during 
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critical illness and inflammatory syndromes may compromise GPx activity.152 Despite its 
importance to antioxidant function (as well as thyroid and immune function), the impact of 
ECMO on selenium levels has not been previously investigated. We hypothesised that the 
addition of an ECMO circuit to a critically ill host would result in selenium reductions, and 
exacerbate oxidative stress levels. We sought to investigate the impact of acute lung injury, 
(i.e. critical injury), ECMO and transfusion, individually and in combination on oxidant status 
and plasma selenium levels using an ovine model of smoke induced acute lung injury (S-
ALI).  
Materials and Methods  
The animal ethics committees of The University Of Queensland (QUT/194/12) and The 
Queensland University of Technology (1100000053) approved this study that adhered to the 
National Health and Medical Research Council (NHMRC) Code of Practice for the Care and 
Use of Animals for Scientific Purposes.227 Forty Australian Samm Border Leicester Cross 
ewes (1 - 3 yr old) were divided into the following groups: (i) healthy control (n = 4), (ii) 
ECMO control (healthy sheep + ECMO, n = 7), (iii) S-ALI control (n = 7), (iv) S-ALI + ECMO 
(n = 8) and (v) S-ALI + ECMO + PRBC transfusion (n = 14). Half of the transfused group 
received fresh PRBC (< 5 days old) and the other half received aged PRBC (> 35 days old). 
Animal Preparation: 
Sheep were allocated to five different groups. Each sheep was anaesthetised and 
instrumented as previously detailed.228 Briefly, standard monitoring was utilised, including- 
arterial blood pressure; three-lead electrocardiograph (ECG); oxygen saturation monitoring; 
continuous hemodynamic monitoring; regular blood gas analysis (ABL825 blood gas 
analyser, Radiometer, Copenhagen, Denmark); and continuous cardiac output (CCO) and 
SvO2 monitoring (Swan-Ganz CCOmbo, Edwards Lifesciences, California, USA). Sheep 
were ventilated through a 10Fr tracheostomy tube. Normothermia (39 ºC) was maintained 
with a warming blanket.  
Experimental Protocol 
Acute lung injury was delivered as previously described.229 Cooled cotton smoke was 
administered through a custom designed hand ventilator. Animals received a total of 14 
breaths of cotton smoke (or sham for controls) to achieve a carboxyhaemoglobin (COHb) 
level of 35-45%. A two-hour lung injury development period was allowed prior to initiating 
ECMO. 
ECMO Circuits 
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The ECMO circuits comprised a Quadrox PLS oxygenator, Bioline tubing and Rotaflow 
pump head (Maquet Cardiopulmonary AG, Hechinger Strabe Germany). Circuits were 
primed with Plasma-lyte P-148 (Baxter Healthcare Pty Ltd. Toongabbie, NSW, Australia), 
4% human albumin (CSL Behring. Broadmeadows, Vic, Australia), 1000IU porcine heparin 
(Pfizer Australia Pty Ltd. West Ryde, NSW, Australia) and warmed to 38 ºC. Target ECMO 
flows were calculated at two thirds of the pre-ECMO cardiac output. Sodium chloride (0.9%) 
(Baxter Healthcare Pty Ltd. Toongabbie, NSW, Australia) was administered intravenously 
as needed to maintain the target ECMO flows. FiO2 was set at 100% and ECMO gas flows 
set to a ratio 0.8:1 of blood flow. Anticoagulation was achieved with 3000 IU of heparin 
given to the sheep prior to ECMO cannulation and the activated clotting time (ACT) was 
targeted between 200 - 300sec. Cannulae were a 19 Fr (return cannula) and a 21 Fr 
(access cannula) Carmeda bonded femoral venous cannula (Medtronic Pty Ltd, 
Minneapolis, MN) positioned via the right external jugular vein. Final cannulae position was 
confirmed using a technique of intra-cannula echo using an intra-cardiac echocardiography 
probe.230 
Bilateral 20 Fr intercostal catheters were inserted two hours after commencement of ECMO 
to collect pleural effusion fluid. After 24 hours sheep were euthanized using sodium 
pentobarbitone (100 mg/kg).  
Ovine PRBC preparation  
Sheep in the transfusion arm received two units of leukofiltered cross-match compatible 
ovine PRBC that were (i) less than 5 days (fresh) or (ii) 35 - 42 days (aged) old using a 
previously described protocol.204 Transfusion of the PRBC commenced after the 6 hr 
samples had been collected.  
Blood Sample Collection 
Arterial blood samples were collected at anaesthetic induction (baseline), after smoke injury 
(PS), 15 minutes after ECMO commencement (0.25 hr) then at 1, 2, 6, 7, 12, and 24 hours. 
Blood for selenium analysis was collected into trace free element tubes (Greiner Bio-One, 
Monroe, North Carolina, United States), and the separated plasma was stored at 4 C until 
analysis. EDTA blood samples were immediately centrifuged 3000g x 10min @ 4 C and 
plasma stored at -80 C for analysis of thiobarbituric acid reactive substances (TBARS) and 
GPx. 
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Measurement of Selenium, GPx and TBARS  
Plasma selenium levels were analysed by graphite furnace atomic absorption spectrometry 
with Zeeman background correction (GF-AAS) using a Varian AA280Z analyser (Agilent 
Technologies Inc, Santa Clara CA, United States) as previously described.231 Inter-assay 
imprecision was 5.5%. Plasma TBARS and GPx were analysed using commercially 
available assay kits (Cayman Chemical Company, Ann Arbor, MI).    
Baseline data depicted in Figure 6-3 (A, B and C) include baseline data from all groups (i.e. 
n = 40). 
Statistical Analysis 
Summary data are displayed as mean ± standard deviation with associated 95% C.I. 
(difference of the mean) unless otherwise stated. A two-way ANOVA with unmatched pairs 
and a Tukey post hoc correction was used to compare means within and between groups 
(Graphpad Prism 6.0a). Statistical significance was assumed when p < 0.05. A linear 
regression was performed to determine the relationship between selenium and GPx or 
selenium and TBARS (Graphpad Prism 6.0a). 
Results 
The sheep in this study weighed an average of 48.6 ± 6.0 kg. Table 6-1 summarises PaO2, 
and COHb levels, heart rate, mean arterial pressure (MAP), inotrope use (noradrenaline, 
dopamine and vasopressin) and fluid requirements across the various study groups. COHb 
levels ranged from 25.3 - 53.6% after smoke injury, while PaO2 levels progressively 
declined in the S-ALI control sheep over the 24 hours period (Table 6-1). Heart rate was 
similar across all the groups, however the average MAP over the study period was lower in 
the S-ALI control, S-ALI + ECMO and S-ALI + ECMO + Tf sheep compared to healthy 
control and ECMO controls. Inotropes (noradrenaline and dopamine) were required in the 
S-ALI control, S-ALI + ECMO and S-ALI + ECMO + Tf sheep to maintain cardiac function 
and blood pressure, but not in the healthy control or ECMO control sheep. Vasopressin was 
required in 5/8 of the S-ALI + ECMO and 4/14 of the S-ALI + ECMO + Tf sheep as they 
were mildly vasoplegic and non-responsive to noradrenaline (Table 6-1). Saline was 
administered intravenously as required to maintain ECMO flows at two-thirds cardiac output. 
As a result sheep in the S-ALI control, S-ALI + ECMO and S-ALI + ECMO + Tf groups 
received significantly more fluids and thus had a positive fluid balance at 24hr. Despite 
these sheep having a higher positive fluid balance, there was no significant difference in Hb 
compared to the ECMO control sheep. (Figure 6-2A).  
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Serial changes to relevant biochemical parameters are detailed in Figure 6-2. The pH levels 
remained consistent throughout the study (Figure 6-2B). Albumin levels were reduced 
significantly (p < 0.05) in the S-ALI control and S-ALI + ECMO groups after 6 hours Figure 
6-2C). Bilirubin levels rose significantly in the healthy control and ECMO control sheep (p < 
0.05) after 12 and 18 hours respectively but remained unchanged in the S-ALI control and 
S-ALI + ECMO groups (Figure 6-2F). Samples in S-ALI + ECMO +Tf group were 
unavailable for albumin, creatinine, alanine transaminase (ALT) and bilirubin analysis. As no 
significant differences were detected between fresh and aged PRBC transfused sheep for 
plasma TBARS, selenium and GPx, the data was combined into a single transfusion group 
(n = 14) and henceforth labelled S-ALI + ECMO + Tf.  
 
Figure 6-2: Effect of ECMO and/or S-ALI on parameters of haemoglobin (A), pH (B), 
albumin (C), creatinine (D), alanine transaminase (E) and bilirubin (F).  
 
Plasma Thiobarbituric Acid Reactive Substances (TBARS) 
Plasma TBARS levels remained unchanged in the healthy control sheep (Figure 6-3A). 
Compared to the healthy control sheep, plasma TBARS were significantly higher at 
corresponding time points between 0.25 hr and 24 hr for all other groups (p < 0.001). 
Plasma TBARS were significantly elevated in S-ALI control sheep, peaking at 2 hr (1.32 ± 
0.40 to 2.90 ± 0.35 µM, 95% CI -2.78 to -1.16; p < 0.001). Plasma TBARS rose rapidly with 
PS, post-smoke injury; ALT, alanine transaminase. Numbers represent hours of ECMO support. a 
and b in C indicate significant difference (p < 0.05) with respect to healthy control and ECMO 
control. Asterisks indicate significant difference (p < 0.05) with respect to baseline. 
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the initiation of ECMO in ECMO control sheep, peaking at 6 hr (1.32 ± 0.40 to 3.11 ± 0.70 
µM, 95% CI -2.60 to -0.98; p < 0.0001). In S-ALI + ECMO sheep plasma TBARS were 
155% above baseline (1.32 ± 0.40 vs 3.37 ± 0.35 µM, 95% CI -2.82 to -1.29; p < 0.0001) 
and 200% above baseline in S-ALI + ECMO + Tf sheep at 24 hr (1.32 ± 0.40 vs. 3.97 ± 0.44 
µM, 95% CI -3.27 to -2.04; p < 0.0001), but this was not significantly higher than S-ALI 
control or ECMO control. No differences were detected due to PRBC transfusion between 7 
hr and 24 hr in the S-ALI + ECMO + Tf group. 
 Healthy 
Control  
(n = 4) 
ECMO 
control  
(n = 7) 
S-ALI Control 
(n = 7) 
S-ALI + ECMO 
(n = 8) 
S-ALI + ECMO + Tf 
(n = 14) 
PaO2 (mmHg) 
Pre-ECMO 
24 hr 
 
533 ± 39 
526 ± 23 
 
395 ± 162 
148 ± 40 
 
562 ± 27 
169 ± 148 
 
409 ± 120 
161 ± 48 
 
403 ± 172 
139 ± 24 
COHb (%) 
[range] 
4.0 ± 0.4 
[3.6 – 4.3] 
4.2 ± 0.6 
[3.5 – 4.7] 
43.3 ± 8.8 
[30.5 – 53.6] 
44.2 ± 5.6 
[35.0 – 51.4] 
39.35 ± 6.40 
[25.3 – 48.4] 
Heart Rate 108 ± 16 102 ± 17 114 ± 17 103 ± 17 100 ± 15 
MAP (mmHg) 
 
120 ± 15 108 ± 18 85 ± 22 81 ± 22 89 ± 22 
Inotropes 
Noradrenaline (µg/min) 
 
0 
 
0 
 
11.9 ± 9.3  
(n = 5/7) 
 
11.6 ± 4.4  
(n = 8/8) 
 
9.17 ± 3.9  
(n = 13/14) 
Dopamine (µg/min) 0 0 220 ± 92  
(n = 4/7) 
163 ± 103  
(n = 7/8) 
136 ±49  
(n = 9/14) 
Vasopressin (unit/hr) 0 0 0 3.3 ± 1.1  
(n = 5/8) 
3.4 ± 1.3  
(n = 4/14) 
Fluid Balance  
@ 24hr (ml) 
378 ± 251 1289 ± 820 4346 ± 1270 9226 ± 2244* 9698 ± 2514* 
Plasma Selenium levels 
Baseline plasma selenium levels were similar amongst all sheep. In ECMO control sheep, 
plasma selenium levels declined at 2 hr to 46% (1.36 ± 0.20 to 0.73 ± 0.21 µmol/L. 95% CI 
0.29 to 0.97; p < 0.0001). They rose after 6 hr but were still below baseline at 24 hr (0.96 ± 
Table 6-1: Comparison of basic physiological variables 
COHb, carboxyhemoglobin; Tf, transfusion; MAP, mean arterial pressure. COHb values are after 
smoke breath cycles completed. Heart rate, MAP and Inotrope values are mean ± S.D. for the period 
between smoke injury/SHAM (2 h prior to ECMO) and 24 h ECMO. Asterisk denotes comparison 
between S-ALI control and S-ALI + ECMO/SALI + ECMO + transfusion (p < 0.05). 
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0.17 µmol/L. 95% CI 0.06 to 0.74; p < 0.01). In S-ALI control sheep plasma selenium began 
to decline at 6 hr, and were significantly below baseline levels at 24 hr (54% reduction; 1.36 
± 0.20 to 0.63 ± 0.27 µmol/L at 24h. 95% CI, 0.39 to 1.07; p < 0.0001) (Figure 6-3B). The 
double insult of S-ALI followed by ECMO produced the greatest decline in plasma selenium 
of 72% at 24 hr (1.36 ± 0.20 to 0.38 ± 0.19, 95% CI 0.66 to 1.3; p < 0.0001). Between group 
comparisons of plasma selenium results detected a significant difference between S-ALI + 
ECMO vs. ECMO control at 24 hr (0.38 ± 0.19 vs. 0.96 ± 0.17 µmol/L, 95% CI 0.15 to 1.01; 
p < 0.001). PRBC transfusions did not cause any change.  
 
Figure 6-3: Effects of smoke injury (S-ALI) ± ECMO ± transfusion (Tf) on (A) plasma 
  thiobarbituric acid reactive substances (TBARS), (B) selenium and (C) 
glutathione peroxidase (GPx) levels. 
The mean baseline data is represented by a full horizontal line. Dashed horizontal line is ± 1SD. 
PS-2h post smoke/sham injury. Numbers represent hours after initiation of ECMO support. Data 
are mean ± SD. Asterisks indicate significant within group difference compared to baseline levels. 
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Pleural effusion fluid collected from S-ALI+ ECMO sheep had selenium levels of 0.5 ± 0.1 
µmol/L (n = 16). Linear regression revealed that decreased plasma selenium was 
associated with increased plasma TBARS for S-ALI + ECMO sheep (r2 = 0.50, p < 0.0001). 
This association was reduced when data from all sheep on ECMO was combined (healthy 
and S-ALI; r2 = 0.39, p < 0.001).  
Plasma Glutathione Peroxidase activity 
No changes in plasma GPx activity occurred in healthy control sheep (Figure 6-3C). 
Though not statistically significant, the following trends were observed: (i) Smoke injury (S-
ALI control) induced a rapid but transient increase in plasma GPx, (1.93 ± 0.55 to 2.67 ± 
0.32 nmol/min/ml), returning to baseline levels at 24 hr (1.94 ± 0.41 nmol/min/ml). (ii) 
ECMO-control experienced a similar increase in plasma GPx (1.93 ± 0.55 to 2.63 ± 0.47 
nmol/min/ml) after ECMO initiation, trending back to baseline levels at 24 hr. (iii) S-ALI + 
ECMO produced peak plasma GPx responses similar to ECMO control (2.86 ± 0.6 
nmol/min/ml), which then declined 1h after ECMO began, being below baseline at 24 hr 
(1.43 ± 0.24 vs. 1.93 ± 0.55 nmol/min/ml). (iv) plasma GPx activity was elevated after 
smoke injury and during the initial stages of ECMO in ECMO + S-ALI + Tf group. No effect 
of PRBC transfusion was detected.   
Discussion  
This ovine model has generated two significant findings. First, we found that both S-ALI and 
ECMO independently increased oxidative stress, but when conducted sequentially (i.e. S-
ALI followed by ECMO) the latter caused no additional impact on oxidative stress. Secondly, 
S-ALI caused significant reductions in plasma selenium, and subsequent ECMO support 
exacerbated this loss.  
ARDS is associated with a dramatic and uncontrolled increase in ROS production that 
contributes to morbidity and mortality.44,232 When conventional medicine fails in these 
patients, ECMO is one of the few remaining life-saving options.218 Previous ECMO studies 
in paediatrics,69 rabbits,67 lambs,68 sheep150 and pigs149 have shown significant elevations in 
lipid peroxides. However, it is difficult to translate these findings to critically ill adult patients 
as (i) paediatric patients have significantly different bodyweight to ECMO surface area ratios 
and (ii) (with the exception of the sheep study150) in all the other animal models ECMO was 
initiated in a healthy host. Thus, the impact of acute illness on overall oxidative stress could 
not be determined.  
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We demonstrated that both S-ALI and ECMO independently increased lipid peroxidation in 
plasma. Over the 24 hr study period, we found that while ECMO use in sheep with S-ALI 
resulted in an increase in lipid peroxides, the levels were not significantly greater than for S-
ALI or ECMO alone. Our results contradict the findings of an earlier similar study,150 which 
measured lipid peroxides in a model of S-ALI and veno-arterial ECMO, and demonstrated 
significant increases in lipid peroxides after ECMO was initiated in a S-ALI animal. As that 
study was conducted 20 years ago, their ECMO circuit was significantly different, which may 
account for the disparity in results to our study. Their circuit included a silicon membrane 
oxygenator with a large surface area (4.5 m2), a servo controlled roller pump and venous 
blood drainage reservoir in a venous arterial ECMO configuration. In comparison, our study 
utilised a low volume closed circuit, PMP fibre oxygenator, (surface area 1.8 m2), with 
centrifugal pump and coated tubing in a VV-ECMO configuration. We speculate that the 
improvements in ECMO technology and circuit biocompatibility have reduced the trauma 
associated with continual blood exposure to the foreign circuit and consequently dampened 
any increase in lipid peroxidation.  
Independent of oxidative stress, reductions in serum or plasma selenium during sepsis and 
ARDS are associated with multi-organ failure, inflammatory syndromes, increased infections 
and increased mortality.13,44,153,232,233 Some studies have shown that selenium replacement 
in critically ill patients is beneficial in reducing infections (such as ventilator acquired 
pneumonia) and mortality.128,234 This led us to investigate the impact of ECMO on plasma 
selenium levels. We demonstrated that S-ALI and ECMO independently led to significant 
reductions in plasma selenium (54 and 46% respectively). Notably the “two-hit” combination 
of S-ALI + ECMO resulted in a greater loss (72%). We postulate that the observed plasma 
selenium reductions may be attributed to an acute phase response, circuit adsorption and 
haemodilution (due to the ECMO priming solution and ongoing fluid replacement). The 
acute phase response seen during inflammatory syndromes increases the permeability of 
cellular membranes to proteins and micronutrients, that are redistributed to tissues.235 
Hypoalbuminaemia, ascites, high volume requirement and significant pleural effusions 
confirm the presence of an acute phase response in the sheep of this current study. 
Measurement of the selenium concentration in the pleural effusion fluid also confirms this 
fluid to be one avenue of significant selenium loss. This may have some clinical relevance, 
as pleural effusions are not uncommon in VV-ECMO patients.  
We have previously demonstrated that CPB circuits adsorb trace elements.47 Given the 
similarities between CPB and ECMO circuits this presents another mechanism for the loss 
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of trace elements such as selenium. In addition, because patients on ECMO are critically ill, 
the associated altered gut motility and absorption may compromise dietary intake of trace 
elements.236 Since ECMO support often lasts for over a week, the combination of acute 
phase redistribution, decreased dietary intake and loss through circuits adsorption could 
lead to a true selenium deficiency. 
While many studies cite plasma or serum selenium reductions in the critically ill as an 
independent predictor of poor outcome, it is important to recognise that plasma selenium 
levels provide limited information regarding functional selenium status. Selenium in plasma 
exists in several forms, 40 - 70% is in the functional form selenoprotein P, GPx-3 accounts 
for another 20 - 40% and 6 - 10% is bound to albumin.237 Unfortunately, in this present 
study we did not have the capacity to measure selenoprotein P. Plasma GPx (GPx-3) is an 
important extracellular antioxidant and can be used at times as a surrogate marker of 
selenium status. GPx is produced primarily in the kidneys and secondarily in the liver,238 
and while the association between selenium and GPx activity is well established, how 
rapidly GPx synthesis in the kidneys and liver is altered by acute reductions in selenium is 
largely unknown. We attempted to measure kidney (creatinine) and liver function (bilirubin 
and ALT). Creatinine levels remained stable in all groups, however there were increased 
bilirubin levels in the healthy control and ECMO control sheep but these were stable in the 
S-ALI control and S-ALI + ECMO sheep (Figure 6-2E). In contrast ALT levels were similar 
across the study groups (Figure 6-2F). The inconsistency between bilirubin and ALT levels 
suggests that the high positive fluid balance in the S-ALI control and S-ALI + ECMO sheep 
has possibly diluted both bilirubin and ALT levels. For GPx activity our data suggests a 
trend towards GPx reductions after 6 hours in S-ALI + ECMO sheep, which may be 
indicative of a delayed response to the reductions in plasma selenium.   
ECMO patients often required multiple transfusions,239,240 which may convey an increased 
risk of transfusion related complications. Previous studies in neonates and animals have 
demonstrated increases in lipid peroxidation after PRBC transfusions.56,57,199,241 We and 
others have shown that PRBC contain low selenium levels158 and reduced antioxidant 
capacity.242 Despite these observations, in this model PRBC transfusions had no significant 
impact on oxidative stress, selenium or GPx. One reason for the lack of response may be 
because of the small volume of PRBC transfused and the period of observation was too 
short. In addition, the magnitude of the S-ALI induced oxidative stress and selenium 
alterations could have masked any transfusion related effect. Thus the effect of massive 
PRBC transfusion during a prolonged ECMO course remains to be investigated.  
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Investigations into the in vivo impact of ECMO using modern adult ECMO cannulae and 
circuits can only be performed with a large animal model. Sheep models have the 
advantage of being similar to humans in weight ranges, cardiopulmonary physiology, 
coagulation and inflammatory systems.228 However, large animal models are expensive and 
this limitation restricted the sample size of each group in our study. The incremental design 
of this in vivo study enabled the differentiation of the effect of ECMO from that of other 
variables such as S-ALI and transfusion, but also had several limitations. The complexity of 
maintaining a critically ill animal restricted the duration of the experiment to 24 hours, thus 
preventing the study of longer-term effects on oxidative stress. While this study utilised a 
common measure of lipid peroxidation (TBARS), it may have benefited from analysing F2-
isoprostanes or protein carbonyl measurements. The analysis of tissue samples from 
specific organs may have also revealed localized decreases in selenium as well as the 
consequences of oxidative stress, that were not apparent using systemic blood samples. 
However, in an ECMO model where sheep are anticoagulated, serial tissue samples are not 
practical due to the risk of catastrophic bleeding.  
During VV-ECMO, blood flow is a key determinant of oxygenation as significant shunting 
can occur in injured lungs, and suboptimal ECMO flows may result in systemic hypoxia. 
Clinically, patients with a high cardiac output who are dependent on higher ECMO flows for 
oxygenation require a degree of fluid resuscitation. Alternatives to optimise oxygenation and 
minimize fluid resuscitation in these patients include pharmacological interventions to 
reduce cardiac output, deep sedation, paralysis or induced hypothermia. To avoid additional 
confounders in this study, we chose to maintain ECMO flows to 2/3 of cardiac output across 
all sheep and to only use fluids and vasoactive agents to achieve this. Despite the high 
dose vasopressor and inotrope drugs in the S-ALI sheep (Table 6-1), the excessive 
capillary leak necessitated significant fluid resuscitation to maintain target ECMO blood 
flows. Notwithstanding this effort, we acknowledge that the resulting higher fluid balance in 
S-ALI + ECMO ± Tf sheep, (Table 6-1) may have contributed to lower selenium levels and a 
blunted TBARS response.   
Conclusions 
We have demonstrated that 24 hours of ECMO induced increased plasma TBARS in a 
healthy host. However, in a S-ALI animal, ECMO did not cause any additional TBARS 
increase. Nevertheless, the combination of S-ALI and ECMO lead to profound reductions in 
plasma selenium. It is unclear if this represents a true deficiency or is a result of fluid shifts 
associated with the acute phase response. In addition to influencing antioxidant function, 
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reductions in plasma selenium may also compromise the function of thyroid and immune 
function. Clinical studies are now needed to confirm if these effects, on selenium and 
oxidative stress, are augmented or diminished with longer periods of ECMO support, and to 
assess if normalisation of selenium through supplementation is beneficial.  
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Rationale 
Atrial fibrillation after cardiac surgery is one of the most common complications and its 
impact on the patient involves quantifiable aspects (hemodynamic instability, stroke risk) as 
well as non-quantifiable aspects (stress). In addition, there is an economic burden on the 
health system as patients stay longer in hospital after surgery, or require ongoing 
medication. There is a reduction in POAF when prophylactic strategies such as ß-blockers, 
sotalol, amiodarone, magnesium, and atrial pacing are used. However, these strategies are 
not always successful or appropriate for everyone. In addition to certain recognized risk 
factors, evidence indicates that oxidative stress and inflammation are key aspects to the 
development of POAF, with both of these elevated during cardiac surgery involving CPB. 
This knowledge has led a relatively small number of studies to investigate whether 
prophylactic antioxidant supplementation reduces the incidence of POAF. There has been 
some success with vitamins C and E. Both of these antioxidants however, are classified as 
non-enzyme “chain breaking” antioxidants, meaning they stop lipid peroxidation after the 
process has started and some damage has already occurred. Primary enzyme antioxidants, 
such as GPx, have the ability to directly interact with and neutralize ROS before damage 
occurs, and therefore have a greater potential to maintain redox balance. As selenium is 
key to GPx activity, we theorized that selenium supplementation might be of significant 
prophylactic value in reducing the incidence of POAF. However, as many selenium 
supplementation studies in the critically ill have failed to actually show a clinical benefit, this 
study was designed to:  
 determine if low pre-operative selenium levels increased the risk (or incidence) of 
POAF in the cardiac surgical population, 
 determine if low pre-operative selenium levels increased post-operative ICU stay. 
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The results of this investigation would help determine if pre-operative selenium assessment 
and supplementation may be beneficial. 
Significance 
Several significant findings arose from this study. The first was that low pre-operative 
selenium levels were independently associated with POAF in patients who had a high 
surgical risk score. In these patients, mean pre-operative selenium levels were 0.73 ± 0.16 
µmol/L, which was significantly lower than levels in those who did not develop POAF and 
had normal sinus rhythm (0.89 ± 0.13 µmol/L, p = 0.005). Half of the patients (53%) with a 
high surgical risk score had pre-operative selenium levels below the normal reference 
range.  
Secondly, this study observed that patients with a pre-operative selenium level below 0.7 
µmol/L had significantly longer ICU stay compared to patients whose pre-operative level 
was ≥ 0.8 µmol/L. 
The results of this study indicates that pre-operative selenium level assessment in high-risk 
patients, and supplementing patients with levels ≤ 0.7 µmol/L may be beneficial. Whether 
supplementation can normalise selenium levels and lead to a reduced incidence of adverse 
complications after cardiac surgery (including POAF) remains to be investigated. 
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The association between pre-operative selenium and post-operative atrial fibrillation 
after high-risk coronary artery surgery. 
 
Abstract 
Objectives: The primary objective of this study was to investigate whether an association 
exists between low selenium levels and the development of post-operative atrial fibrillation 
(POAF) in cardiac surgical patients. POAF is one of the most frequent complications after 
cardiac surgery, with oxidative stress and reduced antioxidant function playing major roles 
in its development. Selenium is a key trace element with antioxidant properties and studies 
document significant reductions during cardiac surgery. Secondary aspects investigated 
were antioxidant function, oxidative stress levels and intensive care length of stay. 
Methods: Fifty patients having primary coronary artery bypass (CABG) surgery with 
cardiopulmonary bypass (CPB) were divided into two groups based on their Society of 
Thoracic Surgeons Mortality risk (STS) score: (i) low-risk group with STS ≤ 0.5% (n = 26) or 
(ii) high-risk group with STS ≥ 2.0% (n = 24). Blood samples were taken at anaesthetic 
induction, after aortic cross clamp removal, 3hr post CPB and post-operative day 1 and 5. 
Samples were analysed for selenium, glutathione peroxidase (GPx) and malondialdehyde 
(MDA). Patients had ECG monitoring in the post-operative period. Bayesian multiple logistic 
regression analysis was used to estimate the independent association of selenium from pre-
operative variables with possible associations to the development of POAF (p < 0.05). 
Results: Seventeen patients developed POAF (14 patients in the high-risk group and 3 in 
the low-risk). Pre-operative selenium was lower in patients who developed POAF compared 
to those with normal sinus rhythm (0.73 ± 0.16 vs. 0.89 ± 0.13 µmol/L, p = 0.005) and this 
was independently associated with POAF in high-risk patients (p = 0.016). Selenium 
remained lower at all time points in those that developed POAF. Lower GPx activity and 
MDA levels were not independently associated with POAF. Independent of POAF, high-risk 
patients had lower pre-operative selenium than those with an STS ≤ 0.5% (0.77 ± 0.15 vs. 
0.89 ± 0.14 µmol/L; p = 0.004). 
Conclusion: High-risk patients with lower pre-operative selenium levels may be at greater 
risk of developing POAF following CABG. The association between selenium 
concentrations, operative risk and POAF demonstrated in this study raises questions of 
whether selenium supplementation in cardiac surgical patients may reduce their POAF risk.  
 
Trial Registration: Australia and New Zealand Clinical Trials Registry: 
ACTRN12612000934842 
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Introduction: 
Post-operative atrial fibrillation (POAF) is one of the most frequent complications after 
cardiac surgery with an incidence of 10-60%.131,243 It significantly contributes to patient 
morbidity with direct translation to higher health care costs.137,244 While the pathogenesis of 
POAF itself is still not clearly defined, currently accepted risk factors for the development of 
POAF include age, type of cardiac surgery, prolonged perioperative ischemia, chronic 
obstructive pulmonary disease (COPD) and postoperative pneumonia.136,245 Current 
evidence suggests the development of POAF is multi-factorial involving a trigger and an 
electrophysiologic/structural substrate,137,243,244 with inflammation and oxidative stress also 
contributing to this pathology.7,8,243 Pharmacological prophylactic therapies and/or surgical 
correction for POAF are not appropriate for all patients. Current treatment options have 
variable efficacy and are associated with frequent and significant side effects.244 The 
variability in current prevention regimens for POAF has lead to research investigating 
alternative or adjunctive strategies, including the use of antioxidants.145 Antioxidants may be 
used as prophylactic and/or therapeutic agents to reduce levels of reactive oxygen species 
(ROS), which contribute to increased myocardial oxidative stress and subsequently POAF. 
However, while few studies have investigated the association between circulating 
antioxidants and POAF, reductions in antioxidant trace elements such as zinc and copper 
have been associated with a higher incidence of POAF.246 Evidence is also emerging 
documenting that a reduction in POAF occurs after administration of the antioxidant 
vitamins C and E.87,145  
 
The trace element selenium is an essential component of at least 25 selenoproteins, which 
play a role in the cellular redox processes, and thus has been considered as the 
cornerstone of antioxidant defence.247 One of the key seleno-enzymes in the antioxidant 
process is the enzyme glutathione peroxidase (GPx), which can be used as a surrogate 
marker for both selenium and oxidative stress status.247 This enzyme acts as a catalyst for 
the reduction of lipid hydroperoxides, thereby protecting cells and tissue from the 
deleterious effects of lipid peroxidation. Adequate levels of selenium are required for normal 
GPx activity, and maximal GPx activity occurs only when plasma selenium levels exceed 
1.0 µmol/L.248 In cardiac surgical patients reduced selenium levels and GPx activity are 
sometimes associated with worse outcomes.14 Some studies have reported that a majority 
of cardiac surgical patients present to theatre with lower selenium levels,249 and that low 
selenium levels may be inversely related to surgical risk.14 A recent study has documented 
that pre-operative selenium levels are weakly associated with post-operative mortality, and 
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that patients who had chronic AF had lower selenium levels before surgery.14 However, this 
study did not differentiate patients according to surgical risk, assess whether selenium 
levels were associated with the development of POAF, or investigate aspects of oxidative 
stress. Therefore we investigated if low pre-operative selenium levels in cardiac surgical 
patients are associated with either POAF or increased length of stay in the intensive care 
unit (ICU), and whether this association was stronger in patients with more pre-operative co-
morbidities. 
Materials and Methods 
Patient Population 
This was a prospective observational study of patients having primary CABG at The Prince 
Charles Hospital, Brisbane Australia. After Human Research Ethics Committee approval 
(HREC/11/QPCH/138) prospective patients were initially screened using the Society of 
Thoracic Surgeons predicted risk of mortality (STS) score.250 To investigate the association 
between selenium levels, POAF and length of time in ICU in high-risk patients, fifty cardiac 
surgical patients having primary CABG surgery were recruited to the study and divided into 
two groups based on their STS score: (i) low-risk group with STS ≤ 0.5% (n = 26) or (ii) 
high-risk group with STS ≥ 2.0% (n = 24). Patients were excluded if they had a history of 
previous cardiac surgery, atrial fibrillation, permanent pacemaker or STS score 0.6 - 1.9%. 
Anaesthesia protocol 
All patients were anaesthetised according to institutional guidelines. Premedication included 
oral temazepam, ranitidine or metoclopramide. General anaesthetic induction was obtained 
with intravenous midazolam, fentanyl and propofol titrated to effect and endotracheal 
intubation was facilitated with intravenously administered rocuronium or pancuronium. 
Anaesthesia was maintained pre-surgery with intravenous propofol and inhalational 
sevoflurane. During CPB, and post-CPB, anaesthesia was maintained with propofol infusion 
and intermittent dosing of fentanyl. Standard cardiac anaesthetic monitoring consisting 
electrocardiogram (ECG), pulse oximetry and bispectral index monitoring, was used. 
Patients were systemically heparinised prior to aortic cannulation and activated clotting time 
(ACT) was confirmed to be > 480 seconds before commencing CPB. At the end of CPB, 
heparin was reversed with protamine sulphate at a 1:1 ratio of the loading dose.  
Cardiopulmonary bypass protocol 
A standardised CPB protocol was used and involved the use of a coated hollow fibre open 
reservoir oxygenator (Medtronic Fusion Oxygenator, “Balance” coated tubing. Medtronic Pty 
Ltd, Minneapolis, MN, USA), priming solution was crystalloid solution (P-148; Baxter 
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Healthcare Pty Ltd, Toongabbie, NSW, Australia), 100 IU heparin (Pfizer, Pty Ltd, Perth, 
Australia), and buffered with sodium bicarbonate (Pfizer, Pty Ltd, Perth, Australia). CPB 
flows were targeted to a cardiac index of 2.5 l/min/m2, coupled with moderate hypothermia 
(32-34ºC) and alpha-stat blood gas management. Myocardial arrest was achieved using an 
induction dose of 1 litre cold crystalloid cardioplegia (antegrade and retrograde) followed by 
subsequent 500 ml cold blood cardioplegia every 20 minutes. Patients were rewarmed to 
36-37ºC prior to separation from CPB. 
Intensive Care Protocol 
Protocolised post-operative care was provided. Where possible, patients were routinely fast-
tracked for extubation and early mobilisation. Routine ICU monitoring comprised a 
continuous 5 lead ECG, invasive arterial blood pressure, central venous pressure, pulse 
oximetry and arterial blood gases as required. Hemodynamic management was guided by a 
combination of static and dynamic hemodynamic indices and involved optimisation of 
patient’s heart rate and rhythm, judicious use of fluids (0.9% saline or 4% albumin) and the 
use of inotropes, inodilators and vasopressors as required to maintain a mean arterial 
pressure of > 65 mm Hg. Discharge from ICU followed unit protocols and the time ready for 
discharge was documented rather than actual discharge time to avoid inaccurate data 
recording associated with “bed-block” in the ward. As per unit protocol, patients were 
monitored by continuous electrocardiography until post-operative day 5 (or they were free of 
POAF). Patient demographics and relevant variables were collected for comparison. 
Blood Sampling and analysis 
Blood samples were collected from existing arterial lines at the following times:  
1) anaesthetic induction (B), 2) after the aortic x-clamp was removed (XC), 3) 3 hours post-
CPB, 4) post-operative day 1 (PD1) and 5) post-operative day 5 (PD5). 
At each time point blood was collected into a trace free elements tube (Greiner Bio-one 
GmbH, Kremsmunster, Austria) and an EDTA tube, and processed within 30 min of 
collection. The separated plasma was stored at -80 °C until analysis. Plasma from trace free 
element tubes was analysed for selenium using graphite furnace atomic absorption 
spectrometry with Zeeman background correction (Varian AA280Z, Agilent Technologies 
Inc, Santa Clara, CA, USA). EDTA plasma was batch analysed for glutathione peroxidase 
(GPx) activity by colorimetric assay. Using this method the predominant variant of GPx 
measured is GPx-3. Malondialdehyde (MDA) by high performance liquid chromatography 
(HPLC) using Waters 2695 Separation Module with a Waters 2474 Fluorescence Detector 
(Waters Corporation-Micromass UK Ltd, Manchester. UK). These tests were conducted in a 
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National Association of Testing Authorities (NATA) accredited pathology laboratory. The 
reference ranges used by this laboratory for selenium and GPx are 0.7 – 1.4 µmol/L and 
210 - 540 U/L respectively. A reference range for MDA has not been determined. 
Statistical analysis 
Continuous variables are presented as mean ± standard deviation (SD) unless otherwise 
stated. Categorical variables are presented as number and percentages. Differences in 
baseline characteristics between the normal sinus rhythm (NSR) and POAF groups were 
evaluated by the student t-test, Chi-squared or Fisher exact test, where appropriate. The 
independent association between significant pre-operative variables and the development of 
POAF identified in the analyses above was tested using a Bayesian multiple logistic 
regression model. A prevalence ratio (PR) and 95% confidence credible interval (95%cI) 
were reported 251. Univariate linear regression and correlation analysis was used to analyse 
the association between selected continuous variables, and results reported as correlation 
coefficient (r) and 95% confidence interval (95%CI). Statistical analysis was carried out 
using Prism (version 6.0a) for the t-test, Chi-squared and Fischer exact tests as well as 
correlation and linear regression. WinBUGS software (version 1.4.3) was used for the 
Bayesian multiple logistic regression252 in Table 2 and 3. A p value of < 0.05, by a two-sided 
test, was considered statistically significant. 
Results 
Patient Characteristics 
Fifty patients were enrolled in the study with an average age 69.8 ± 10.8 years and a male 
dominance (39/50) (Table 7-1). Twenty-four patients were in the high-risk group (STS score 
3.1 ± 0.97) and 26 in the low-risk group (STS score 0.37 ± 0.09). 
In the high-risk group, 14 patients developed POAF (58%) versus three in the low-risk group 
(12%). Analysis of all patients found that patients who developed POAF were older (p < 
0.05), had more co-morbidities (p < 0.05) and lower pre-operative ejection fraction (p < 
0.05). Of the pre-operative biochemical variables creatinine, albumin, selenium and GPx 
were also lower in patients who developed POAF (p < 0.05). Patients who developed POAF 
had a higher sequential organ failure assessment (SOFA) score (p < 0.05) and tended to 
stay longer in ICU (104.5 ± 235.3 vs. 29.5 ± 13.2 hrs), though this extra stay was not 
statistically significant (p = 0.07). No differences between the POAF and NSR groups were 
noted for gender, body mass index (BMI), smoking history, CPB and X-clamp time or length 
of hospital stay (P > 0.05).  
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Table 7-1: Patient characteristics, baseline biochemical data, 
intra- and post-operative variables. 
[NSR–normal sinus 
rhythm; POAF–post 
operative atrial fibrillation; 
STS–Society of Thoracic 
Surgeons Mortality Risk 
score; BMI–body mass 
index; LVEF–left 
ventricular ejection 
fraction; DM– diabetes 
mellitus; MI– myocardial 
infarction; HTN– 
hypertension; GPx– 
glutathione peroxidase; 
MDA–malondialdehyde; 
CPB–cardiopulmonary 
bypass; ICU–intensive 
care unit; APACHE–Acute 
physiology and Chronic 
Health Evaluation ; SOFA–
Sequential Organ Failure 
Assessment score.  
 
[Asterisk indicates 
significant pre-operative 
variables used in the 
multivariate analysis.] 
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Pre-, intra- and post-operative changes in 
plasma selenium. 
Of the 50 patients, 34% (17/50) had pre-
operative selenium levels below the reference 
range of 0.7 – 1.4 µmol/L used in our 
chemical pathology laboratory. Patients who 
developed POAF had lower pre-operative 
selenium levels compared to those in the 
NSR group (Table 7-1; p < 0.005). Of the 
POAF patients 53% (9/17) had selenium 
levels ≤ 0.7 µmol/L, while only 24% (8/33) of 
NSR patients were ≤ 0.7 µmol/L. Both POAF 
and NSR patients demonstrated a decrease 
in selenium levels at cross clamp, with levels 
recovering during and after surgery (Figure 
7-1A). However, patients who developed 
POAF still had significantly lower selenium 
levels than NSR patients at 3hrs, PD 1 and 5 
(p < 0.05). Furthermore, mean selenium 
levels of patients who developed POAF 
remained below the reference range from XC 
onwards.  
High-risk patients with an STS ≥ 2.0% had 
lower pre-operative selenium than low-risk 
patients (STS ≤ 0.5%) (0.77 ± 0.15 vs. 0.89 ± 
0.14 µmol/L; p = 0.004). Selenium levels in 
the high-risk patients stayed significantly 
below low-risk patients 3 hr after CPB and at 
PD1 and 5 (p < 0.01).  
There was a positive correlation between selenium level and GPx activity (Figure 7-2A. r =  
0.55; 95%CI 0.46 to 0.63, p < 0.0001) and a weak but significant negative correlation 
between selenium and age (Figure 7-2B, r = -0.28; 95%CI -0.52 to -0.03, p < 0.048) and 
selenium and MDA levels (Figure 7-2C. r = -0.3; 95%CI -0.41 to -0.18, p < 0.0001).   
 
 
  Figure 7-1: Serial changes in (A) 
selenium, (B) Glutathione peroxidase 
(GPx) and (C) Malondialdehyde (MDA). 
B; pre-operative, XC; after aortic cross-clamp, 
PD; post-operative day 1 or 5. GPx; 
glutathione peroxidase, MDA; 
malondialdehyde. Shaded area represents 
common Australian reference range. Asterisk 
indicates significant difference between groups 
(p < 0.05). 
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To determine if there was an independent association between selenium and the 
development of POAF the significant pre-operative variables from Table 7-1, (indicated by 
asterisk), were analysed by Bayesian multiple logistic regression. Pre-operative selenium 
was not associated with POAF when comparing both low and high-risk patients as a single 
group (Table 7-2; PR 0.77, 95%cI 0.37 to 1.35, p = 0.32). However, when analysing data 
from the high-risk group (n = 24), there was a statistically significant association with 
selenium and the development of POAF (Table 7-3; PR 0.32; 95%cI 0.06 to 0.85, p = 
0.016). Comparing pre-operative selenium from all patients revealed that selenium was not 
associated with an increase length of stay in ICU. However, there was a statistically 
significant association with increased length of stay in ICU with low pre-operative selenium 
levels (threshold of ≤ 0.7 µmol/L) irrespective of the presence of POAF (r = -0.56; CI -0.82 
to -0.11, p = 0.02). This association was not an independent predictor of ICU stay when 
other variables of pre-operative creatinine and define LVEF were considered (p > 0.05).  
 
 
Figure 7-2: Correlations between (A) selenium and GPx, (B) pre-operative 
selenium and age, (C) selenium and MDA and (D) GPx and MDA.  
 
Pre-, Intra and post-operative changes in plasma glutathione peroxidase 
Pre-operative activity of the antioxidant GPx was significantly lower in the POAF group 
(Table 7-1; p < 0.05). GPx activity decreased similarly in patients with POAF and NSR after 
X-clamp removal and then recovered post-operatively at 3 hr, PD 1 and PD 5 (Figure 7-1B). 
GPx activity remained within the reference range throughout recovery; however, patients 
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who developed POAF continued to have significantly lower GPx activity than the NSR group 
at all time points (P < 0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pre-, Intra and post-operative changes in plasma MDA 
Levels of MDA, (a by-product of lipid peroxidation), were similar in patients with POAF and 
NSR at baseline (Table 7-1). MDA levels increased in both groups after the X-clamp was 
removed, but this was not different between the two groups or significantly above baseline. 
At PD 5 MDA levels were significantly higher in patients with POAF (Figure 7-1C p < 0.05). 
There was a significant negative relationship between MDA levels and GPx activity (Figure 
Table 7-2: Variables associated with POAF in low (n = 26) and high-
risk (n = 24) patients. 
Table 7-3: Variables associated with POAF in high-risk patients 
(n = 24). Estimates from multiple logistic regression. 
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7-2D: r = -0.47; 95%CI -0.56 to -0.37, p < 0.0001), such that as GPx activity increased, 
MDA levels decreased. 
Discussion 
POAF is a common complication after cardiac surgery and the overall incidence of POAF in 
this present study (34%) was similar to other published studies with similar patients risk 
profiles (10 - 60%).131,243 POAF usually presents within the first few days following surgery 
and by PD 5 the incidence of new onset POAF has dropped to around 2%.243 Equally POAF 
has often resolved within this time period, suggesting a reversible nature to the condition. 
Cardiac surgery with CPB is known to induce an oxidative stress response, 4 as well as to 
decrease selenium levels.13 Thus it is plausible that these two responses may be linked. In 
addition to intraoperative decreases in selenium, other studies have shown that cardiac 
surgical patients often present for surgery with lower than normal selenium levels.29 Lower 
selenium levels are also predictive of post-operative complications and mortality. A recent 
study has serendipitously recorded lower pre-operative selenium levels in cardiac patients 
with chronic AF;14 however, no studies have thus far investigated what association exists 
between low pre-operative selenium and the development of POAF.  
Data from this study found that CABG patients who developed POAF had significantly lower 
pre-operative selenium levels than those with NSR; furthermore, their post-operative 
selenium levels remained significantly lower. Patients assessed as high-risk (STS ≥ 2.0%) 
also recorded lower pre-operative selenium levels and demonstrated a higher incidence of 
POAF than their low-risk counterparts (STS ≤ 0.5%). Analysis confirms that preoperative 
selenium levels of ≤ 0.7 µmol/L are associated with an increased length of ICU stay (R2 = 
0.31; CI95% -0.82 to -0.11, p = 0.0196), but the association is not present at levels ≥ 0.8 
µmol/L. Thus a pre-operative plasma selenium concentration of ≤ 0.7 µmol/L appears to be 
a useful threshold for assessing POAF risk.  
As has been previously reported, this study also found a linear relationship between 
selenium levels and antioxidant GPx activity.173 However, our results unexpectedly 
determined that lower GPx activity and increased oxidative stress were not independently 
associated with POAF. It is plausible that with a larger sample size an association between 
GPx and POAF may have been detected. The sensitivity of GPx measurement may have 
been enhanced with measurements of intracellular levels of GPx (i.e. GPx-1) instead of only 
GPx-3 (the predominant plasma variant of GPx). In addition, as nearly half of the identified 
selenoproteins in humans have antioxidant activity,81 the possibility remains that 
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selenoproteins other than plasma GPx may have been critically altered during the operative 
and ischemia-reperfusion period.  
Oxidative stress is the imbalance between the production of reactive oxygen species and 
the ability of antioxidants to maintain redox balance. There is compelling evidence to 
suggest that oxidative stress and inflammation are key components to the development of 
POAF.7,8 Increases in myocardial oxidation and systemic serum peroxides have been 
demonstrated in cardiac surgical patients with POAF compared to those with NSR.1 In our 
study we demonstrated a small but significant increase in plasma MDA over the study 
period in those with POAF. While we recorded associations between MDA, selenium and 
GPx (Figure 7-2), we could show no direct association between MDA and POAF. It is 
possible that the measurement of plasma MDA levels may not have been specific enough to 
measure local changes that were present in the myocardium. Ramlawi et al demonstrated 
the value in assessing oxidative stress in myocardial tissue,1 however, we did not have 
access to right atrial tissue in this study. In this study we measured lipid peroxidation via 
MDA but did not measure oxidative stress damage to proteins and DNA, which may have 
given additional supportive evidence of the relationship between selenium and POAF.  
Significant reductions of the antioxidant trace element selenium occur during cardiac 
surgery, and these have been associated with various adverse outcomes.14,29 Given the link 
between oxidative stress and POAF it is plausible that reinforcement of the antioxidant 
response might reduce myocardial oxidative stress, and consequently reduce susceptibility 
to POAF. Antioxidants investigated thus far are vitamin C and E and N-acetylcysteine 
(NAC), yet few studies have shown that the use of antioxidants is associated with a reduced 
incidence of POAF, and the results are variable in those that have. A recent meta-analysis 
and systematic review examined 23 studies and determined that antioxidants such as 
vitamin C have significant capacity to reduce POAF.145 To date, the association between 
selenium and the development of POAF has not been investigated. Our results show that 
low pre-operative selenium levels and high STS scores are associated with post-operative 
POAF. This suggests that correction of low selenium levels prior to cardiac surgery may 
lessen the risk of development of POAF.  
Selenium supplementation in cardiac surgical patients may provide many antioxidant 
benefits, which ultimately result in an attenuated oxidative stress response. Presently there 
is only one study that has investigated the use of selenium supplementation (as a 
monotherapy) in cardiac surgical patients.25 One hundred low-risk cardiac surgical patients 
received a 2000µg dose of selenium followed by 1000 µg I.V. boluses per ICU day and 
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were compared with matched historical controls. The pre-operative selenium levels of 75% 
of their patients were below the normal German reference range (127 - 178 µmol/L). 
Although intravenous selenium was given to raise selenium to normal levels there was no 
improvement in clinical outcome.25 The authors suggest that the administration of 
intravenous selenium just prior to CPB may have been too late to have a protective effect. 
POAF was not documented in that study.  
Our study found that low pre-operative selenium levels of ≤ 0.7 µmol/L is associated with 
increased length of ICU stay, and when combined with a high STS score, is associated with 
a higher risk of developing POAF. This data suggests that pre-operative assessment of 
selenium levels coupled with pre-operative STS risk assessment may identify patients 
susceptible to POAF who may benefit from selenium supplementation.  
Limitations in this study are as follows. Age is an important risk factor for POAF independent 
of surgery,131 and is also associated with a decline in selenium.253 In our study patients who 
developed POAF were older than those with NSR and we demonstrated a small association 
between age and declining pre-operative selenium levels. Additionally, even in the absence 
of co-morbidities, a patient with uncomplicated three vessel disease would achieve an STS 
score > 0.5% simply because they were older than 73 (male) or 68 (female). Therefore our 
patient groups were biased towards older males. It may be no coincidence that age is the 
predominant risk factor for POAF and that age is also related to a reduction in selenium. 
The factors of age and sex on selenium and POAF warrant further investigation. Lastly, the 
study population only represented patients undergoing CABG and whether the findings may 
be extrapolated to patients undergoing valve procedures and combined valve and graft 
procedures remains uncertain. Despite these limitations we believe that the data collected 
during this study will inform future prospective studies investigating the role of selenium in 
POAF vulnerability and whether selenium might be a reasonable prophylactic antioxidant 
supplement in select cardiac surgical patients as an additional adjunct to POAF prevention. 
 
Conclusion 
High-risk patients with low pre-operative selenium levels may be at greater risk of 
developing POAF following CABG. Patients with selenium below 0.7 µmol/L may also have 
an increased ICU length of stay, a finding that needs further confirmation in future studies. 
The assessment of selenium levels pre-operatively in the cardiac patient is not part of 
current practice, nor is the routine normalisation of marginal or low selenium levels. The 
association between selenium concentrations, operative risk and POAF demonstrated in 
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this study suggest that there may be value in pre-operative selenium screening to help 
guide supplementation studies investigating whether selenium normalisation reduces the 
incidence of adverse complications after cardiac surgery, including POAF. 
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Chapter 8 : General Discussion and Conclusion 
 
There were four main hypotheses to this thesis, which examined key aspects of selenium 
and oxidative stress modulation during extracorporeal circulation. The main findings were 
that low pre-operative selenium levels in high-risk patients having cardiac surgery were 
independently associated with POAF. Pre-operative selenium levels below 0.7 µmol/L were 
also predictive of a longer ICU stay irrespective of surgical risk or the development of 
POAF. As a similar threshold has been associated with SIRS,5 it is plausible that selenium 
levels below 0.7 µmol/L may prove to be a useful threshold in future Australian clinical 
studies investigating the benefits of selenium supplementation.  
The ovine ECMO model determined that in the first 24 hours, both lung injury and ECMO 
independently increased oxidative stress, but when conducted sequentially i.e. lung injury 
followed by ECMO, there was no additional impact on oxidative stress. Lung injury caused 
significant reductions in plasma selenium and subsequent ECMO support exacerbated this 
loss.   
In 2010 there was scant literature describing the influence of selenium reductions on 
outcomes in cardiac surgery and critical illness. Despite subsequent studies reporting low 
selenium levels during cardiac surgery and critical illness, there is still a paucity of data 
regarding clinical relevance of these reductions.5,13,14,26,29,254,255 To better understand and 
interpret the data that existed in 2010 and subsequently the data of 2015, several 
demographic, animal and laboratory studies were required to define selenium levels of 
Queensland blood donors, and investigate the effects of PRBC transfusion and the 
relevance of the artificial ECC circuit on selenium and oxidative stress levels. 
Due to significant global variation in selenium there is no universal reference range.248 For 
example in Finland the mean plasma levels is 0.53 µmol/L, while in Pakistan it is 2.72 
µmol/L (Table 1-1).17 Furthermore, even within some countries (such as Pakistan) there are 
huge local variations (range 0.38 – 7.37 µmol/L).17 There are also considerable differences 
across the various regions and states of Australia164-170 (Table 3-2). These variations are 
largely due to variations in soil selenium levels and ultimately the availability of selenium in 
foods.16 Large variations across various populations make it difficult to interpret the 
literature reported effect of low levels on clinical outcome, as the selenium level in the 
relevant local population is required to provide context.  
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In the cardiac surgical and critically ill populations there appears to be significant variability 
between reported selenium levels and their clinical consequences. For example, in 1990 
Antilla et al were the first to demonstrate reductions in selenium in Finnish adult cardiac 
surgical patients undergoing CPB. Levels fell from pre-operative levels of 1.35 µmol/L to 
1.09 µmol/L at POD 4, though they did not record outcomes.254 Similarly, in a U.K. 
paediatric cardiac surgery population selenium levels were reduced from 0.61 µmol/L to 
0.51 µmol/L 48 hrs after surgery.26 Despite these reductions in selenium, no reduction in 
GPx activity was recorded. Lower selenium levels were nevertheless associated with 
increased ICU stay and low circulating levels of the thyroid hormone triiodothyronine (T3). 
More recently Stoppe et al recorded reductions in selenium from pre-surgical levels of 1.13 
to 0.9 µmol/L after surgery in German cardiac patients and determined that low levels were 
independently associated with, and predictive for, the development of MOF.13 In a 2012 
study of 197 Hungarian cardiac patients Koszta et al determined selenium levels after 
cardiac surgery in survivors were significantly higher (1.41 µmol/L) compared to non-
survivors (1.30 µmol/L). They had previously determined the healthy level in the Hungarian 
population to be 1.57 µmol/L.14 Finally in a German study comparing off-pump and on-pump 
cardiac surgical patients, Stevanovic et al determined that a post-operative selenium level of 
0.55 µmol/L in on-pump patients was associated with a decrease in GPx activity as well as 
being associated with the development of various complications.29 These few studies reveal 
the difficulty in interpreting the clinical relevance of selenium reductions from countries that 
have significantly different selenium levels in their healthy populations.  
The data shows that a selenium level may be associated with adverse outcomes in one 
population but not with another. For example, the selenium level of the non-survivors in 
Hungarian cardiac patients (1.30 µmol/L)14 is already higher than the pre-operative levels in 
German study of similar patient population (1.13 µmol/L) who clearly were alive prior to 
surgery.13 While the mean post-operative level associated with MOF in the same German 
study (0.9 µmol/L)13 is significantly higher than the pre-surgical levels in the study 
investigating thyroid dysfunction in a paediatric cardiac surgical population (0.61 µmol/L); 
who also did not present to surgery with MOF or signs of thyroid dysfunction. The data 
available suggests that the measured level of selenium associated with adverse outcomes 
appears less relevant than the percentage change in selenium from pre-surgical or 
background healthy levels, hence the importance of understanding the selenium level in the 
local population. For the Australian cardiac surgical population, our data seems to suggest a 
level lower than 0.7 µmol/L as the level associated with increased ICU stay and (in general) 
a higher incidence of POAF.   
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In the heterogenous population of the critically ill, low selenium levels have also been 
associated with increased rates of infection, increased ICU stay and increased 
morbidity.5,128 The effects of critical illness on selenium levels were first reported in an 
Australian study in 1990. Hawker et al documented low levels of selenium (0.49 µmol/L) in 
175 patients who had been in ICU for 4 weeks, noting that this was considerably lower than 
that of healthy volunteers where the level was 1.05 µmol/L.255 While these levels are truly 
low compared to the Australian reference range, they were not correlated with outcome. 
Forceville et al examined 134 French ICU patients and determined that mean selenium 
levels were lower at admission than the healthy reference mean, and that patients with 
SIRS had significantly lower levels than patients without SIRS (0.62 vs. 0.83 µmol/L).5 They 
also determined that selenium levels lower than 0.7 µmol/L were associated with more 
complications and greater mortality.5 Another study of German ICU patients examined the 
time-course changes of selenium levels, looking for associations with post-operative 
outcome. Nearly all patients had selenium levels below the standard mean healthy value of 
0.94 µmol/L. Patients with SIRS and sepsis had the lowest selenium levels, which 
correlated with APACHE and SOFA scores. A selenium level lower than 0.46 µmol/L was 
also predictive of mortality.153 These variations in selenium level and associated adverse 
outcomes mirror the cardiac surgical population. Unless clinicians can contextualize those 
levels with respect to the normal healthy range of the local population, understanding the 
relevance of certain selenium levels being associated with a reported adverse outcome is 
difficult.  
Objective 1: Define the Queensland Selenium level 
In Chapter 3 the selenium level in a healthy Queensland population was measured in order 
to understand where Queensland levels were situated compared to the global setting. The 
results of this study provided several points of interest that proved useful for other sections 
of this thesis. The average plasma selenium level across the three Queensland regions 
studied was 1.09 µmol/L [85.6 µg/L] (SD 12.9; range 0.7 – 2.21 µmol/L).158 This was 
considerably lower than previously reported levels for Australia,164-170 (Table 3-2) with the 
majority of patients having a level below the minimum level of 1.14 – 1.27 µmol/L required 
for maximal GPx activity.171,173 An additional finding from our study was that cellular 
components i.e. PRBC and pooled buffy coat derived platelets, had very low selenium 
levels. 
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This newly defined selenium level for healthy Queensland blood donors sits in the middle of 
reported global levels, (Table 1-1)17 being similar to Germany,29,13 and potentially giving the 
findings of studies from there more relevance to the results observed in our studies.  
 
Hypothesis 1: CPB circuits will adsorb trace elements and increase oxidative stress. 
As intra-operative reductions in various trace elements have been demonstrated to occur 
during CPB,26,184,246,256,257 we postulated that adsorption to the CPB circuit (either directly or 
via carrier proteins) may explain part or all of these reductions. In Chapter 4 an in vitro CPB 
model was used to test this hypothesis. CPB circuits were primed with fresh whole blood, 
and significant reductions in selenium, zinc and copper were measured.47 These three trace 
elements are required by antioxidant enzymes.183,184,185 Given the closeness of CPB and 
ECMO circuits in design and materials, a similar reduction might be expected to occur 
during ECMO, although this has not yet been demonstrated in any study. Modern CPB and 
ECMO circuits are coated with artificial substances, such as heparin, heparin substitutes 
and phosphorylcholine derivatives258,259 that attempt to mimic the surface of the 
endothelium, reducing protein adsorption and improving the biocompatibility of the artificial 
surface. Despite this there is still evidence of an immediate adherence of plasma proteins 28 
and activation of the inflammatory and coagulation systems after blood contact with the 
surface of the ECC.27,260 Additionally the tubing and fibres of ECC have been shown to 
adsorb an assortment of drugs.261-263  
What is unclear from our current study and that of others is whether these trace elements 
return to circulation after some period of time, or remain bound indefinitely. In cardiac 
surgical patients, where the time spent exposed to the CPB circuit is short, the selenium 
bound to the circuit during CPB will likely be lost from the patient after surgery is complete. 
However, as ECMO typically lasts several days to weeks, it is plausible that selenium (and 
other trace elements) may only be bound to the circuit temporarily as the surface 
environment of the ECMO circuit changes and pacifies over time.27 It was demonstrated 
that coating the circuit with albumin, which preferentially binds to the tubing surface in 
competition with fibrinogen,27 provided no protection in reducing trace element loss. 
Undoubtedly modern coated CPB and ECMO circuits are an improvement to older 
generation circuits (which had no coating), with respect to inflammation and platelet 
activation. However, our results raise the question of whether preloading the circuits with 
key trace elements might be clinically beneficial from this respect.  
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Hypothesis 2: Transfusion of blood products is associated with a reduction in 
selenium and an increase in oxidative stress. 
We had previously demonstrated that PRBC contains very little extracellular selenium158 
and postulated that the transfusion of significant volumes of PRBC would have a dilution 
effect on the selenium levels of the recipient, and thereby compromise the antioxidant 
response leading to an increase in oxidative stress. We investigated this hypothesis using 
an ovine model (Chapter 5) and confirmed a reduction in selenium and an increase in lipid 
peroxidation levels after only two units PRBC for both fresh and aged products.241 This 
effect has previously been reported in paediatric patients.56,57,199  
By using a healthy animal model our data confirms that PRBC transfusion dilutes the 
recipients circulating selenium levels and compromises antioxidant capacity. Previously the 
transfusion of as little as 1-2 units of PRBC has been associated with adverse outcomes in 
cardiac patients.198 Prior to 2015 a number of reports suggested that aged PRBC was 
associated with worse outcomes compared to fresh PRBC.200,264,265 This year (2015) results 
from a multi-centered study of 1098 cardiac patients found that fresh PRBC transfusion was 
not associated with less MOF than aged PRBC transfusion.266 Another multi-centered study 
of 2430 critically ill patients also reported that fresh PRBC transfusion was not superior to 
standard issue PRBC units in reducing 90-day mortality.267 Similar to our findings with the 
ovine model, these studies show that aged PRBC transfusion is not associated with more 
adverse outcomes. Both studies did still document significant adverse outcomes associated 
with transfusion in general, however, there is little consensus on the mechanisms behind 
these adverse outcomes. Further investigation is needed to determine if reduced selenium 
levels and increases in oxidative stress (transfusion related oxidative stress (TROS)) may 
contribute to adverse outcomes after transfusion, especially in cases of massive transfusion 
(> 1 blood volume in 24 hours or > 50% of blood volume in 4 hours268). Other adverse 
aspects of transfusion such as TRIM (transfusion related immuno-modulation), TRALI 
(transfusion related acute lung injury) and TACO (transfusion associated circulatory 
overload),269 which were unrecognized complications a decade ago, are now recognized to 
be part of the adverse outcomes associated with transfusion. Only well designed studies in 
select patient populations will be able to determine the relevance of our results from the 
ovine model. 
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Hypothesis 3: ECMO therapy is associated with significant selenium loss that 
contributes to increased oxidative stress. 
To test the hypothesis that ECMO therapy is associated with significant selenium loss and 
increased oxidative stress, an ovine model of lung injury and ECMO was used to investigate 
the separate and combined effects of each intervention (Chapter 6). We discovered that 
similar to CPB, the introduction of ECMO support in a healthy animal resulted in reductions 
in selenium and increases in oxidative stress. When ECMO therapy followed acute lung 
injury, there was an additive effect of ALI and ECMO on selenium reductions but no 
additional effect on oxidative stress levels.270  
ECMO is used in critically ill patients who are in refractory respiratory and/or cardiac failure 
that has not responded to conventional medical intervention.146,218 While the absolute 
benefit of ECMO in critical illness with refractory cardiorespiratory failure is yet to be 
determined, radiographic evidence suggests that VV-ECMO may temporarily exacerbate 
lung injury (Figure 2-4). In our study we postulated that the additional oxidative stress 
response stimulated by the ECMO circuit was a contributor to this apparent exacerbation. 
Our results did not find this, and this may be because only systemic levels of lipid 
peroxidation were measured, and unfortunately, we did not have the ability to directly 
sample or test pulmonary tissue. In future investigations regarding early and late deleterious 
effects of ECMO therapy (includes ECMO, dialysis and transfusion aspects) additional 
markers of lipid and protein oxidation (such as isoprostanes or protein carbonyls), may 
reveal additional information about this response.  
The selenium reductions noted in the first 24 hours of this animal study are concerning, as 
significant selenium reductions in critically ill patients are associated with worse outcomes, 
independent of oxidative stress. It would be worthwhile to determine if similar reductions 
occur in patients, and to consider selenium supplementation to correct this depletion. Such 
studies would need to consider the metabolic requirements of critically ill patients on ECMO 
as it has been suggested that these patients may be receiving as little as 50% of their 
nutritional requirements.271 While large doses of selenium (well in excess of recommended 
daily allowances 161) seem well tolerated in the critically ill patient,128,272,273 it is unclear 
whether such doses would be tolerated in the ECMO patient over the long term. 
The results of our study have provided considerable additional information regarding the 
isolated and combined effects of acute illness and ECMO on oxidative stress and selenium 
levels. A small number of animal studies were conducted in the late 1990’s and documented 
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increases in lipid peroxidation; however, these studies utilized circuits that had little clinical 
relevance to the modern ECMO circuit.67,68,150 A clinical study investigated oxidative stress 
in paediatric patients on ECMO and also noted increases in lipid peroxides, but that study 
was also conducted in 1990 and also is of little clinical relevance to modern ECMO.69 In 
2014 a porcine study demonstrated significant increases in lipid peroxides in blood and 
tissue after initiating ECMO using current modern circuits.149 However, only one of these 
studies investigated the combined aspects of injury and ECMO150 whereas the other studies 
used healthy animals. Our results suggest the short term effect of ECMO and transfusion is 
not additive in the first 24 hours. What subsequently happens, as time on ECMO increases 
in these patients is, however, unknown. Clinical studies are needed to determine the effects 
of illness, ECMO, dialysis and multiple transfusions over the entire hospital stay and 
investigate aspects of oxidative stress, inflammation and immunity against clinical outcomes 
such as infection, MOF and mortality. 
 
Hypothesis 4: High-risk cardiac surgery patient with low pre-operative selenium 
levels in are more likely to develop POAF. 
POAF is the most common complication after cardiac surgery, increasing operative 
mortality, stroke risk, length of stay in ICU and requires more healthcare dollars to 
treat.243,274 Understanding the mechanisms behind its development and developing 
protocols to reduce its incidence would not only improve patient outcomes, but also produce 
a more cost-effective healthcare service. The development of POAF is multi-factorial274 but 
includes oxidative stress.275 As normal selenium levels are required for appropriate 
antioxidant function to combat the oxidative stress response, it was hypothesized that 
patients with low pre-operative selenium levels were more likely to develop POAF. This 
hypothesis was tested in a group of twenty-six low-risk and twenty-four high-risk patients 
having primary CABG (Chapter 7). Similar to previous studies in cardiac surgical 
patients,13,14 we also determined that more than half of patients with an STS score ≥ 2.0 had 
selenium levels below the Australian reference range. Previously a study of 197 consecutive 
cardiac surgical patients had documented lower pre-operative selenium levels in patients 
with chronic AF,14 however no studies had investigated if an association between pre-
operative selenium levels and POAF in cardiac surgical patients existed. We discovered 
that patients with an STS score ≥ 2.0 (i.e. high-risk group) had multiple co-morbidities and 
risk factors for POAF. In these patients pre-operative selenium was independently 
associated with POAF. We also determined that patients stayed longer in ICU when 
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selenium was ≤ 0.7 µmol/L compared to those with a level ≥ 0.8 µmol/L (irrespective of STS 
score or POAF). While such a threshold may not be applicable globally (due to variability in 
selenium levels), at least one other study has identified the same threshold in a critically ill 
population. In the French study, organ failure and mortality was three-fold higher in those 
with selenium ≤ 0.7 µmol/L.5 We speculate that this threshold, at least in the Australian 
population, may be key to future studies attempting to determine the benefits of selenium 
supplementation in surgical and critically ill populations. 
As described earlier, cardiac surgery with the use of CPB is associated with reductions in 
selenium that are associated with adverse outcomes such as MOF and increased length of 
stay in ICU.13,29 Concurrently there are also increases in oxidative stress,175 although these 
alterations have largely been identified in separate studies to that of selenium 
investigations. That oxidative stress and inflammation are important components to the 
development of POAF, and the realization that many cardiac patients present to surgery 
with suboptimal selenium levels, lends itself to the hypothesis that low pre-operative 
selenium levels may increase the risk of POAF in those patients who had other risk factors 
favoring the development of POAF such as proposed in Figure 2-6. In our study GPx 
activity was lower in patients who developed POAF over the 5-day study period (and 
presumably this was related to the measured selenium reductions); however, our study did 
not measure differences in oxidative stress (as measured by plasma MDA) between those 
with POAF and those with NSR. It is plausible that measuring MDA, isoprostanes or protein 
carbonyls directly from atrial tissue may have revealed a different result. Nevertheless, our 
results appear to be the ideal segue to the next stage of investigations into the benefit of 
selenium supplementation in the cardiac patient.  
 
Limitations 
Each of the studies that constitute this thesis had their limitations, most of which have been 
acknowledged within the discussion of each chapter publication. This section discusses 
limitations that could not be included in the manuscripts due to word limits.  
In attempting to define a selenium level for the Queensland population we chose three 
broad regions across the state. However, within these regions there was only one ARCBS 
collection centre. So in addition to our choice of geographic regions not being representative 
of the whole state it is also plausible that with only a single collection centre our patients 
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were not representative of that region, some of which are quite large and possibly remote. 
Equally, we did not try to discern if there were selenium differences between indigenous and 
non-indigenous Australians. Indigenous Australians suffer from high rates of diabetes and 
cardiovascular disease,276 both of which have been shown to influence selenium levels. 
While no indigenous patients were recruited in this study, understanding selenium levels in 
this sub-population may be highly relevant to future cardiac surgical studies.  
Throughout this study we applied TBARS and MDA as our measures of oxidative stress.  
While these are certainly valid, and popular, measures of lipid peroxidation within the 
literature, they are prone to error.36 As a colorimetric assay, the measurement of TBARS is 
easy to perform for a skilled operator. In one of the first studies of this thesis (Chapter 4) 
there was a steep learning curve to this analysis that resulted in a series of erroneous 
measurements. The limitation can be attributed to the inexperience of the operator (this 
candidate). As a result, some circuit experiments had to be repeated, and extra assay kits 
purchased. In one of the first ovine studies (Chapter 5) the decision was made to move to a 
different brand of TBARS assay that utilized a significantly smaller volume of blood (R&D 
Systems Inc, Minneapolis, MN. USA). However, we were unable to achieve reproducible 
results with ovine blood and the assays were all repeated using the Cayman TBARS assay. 
This experience highlights the potential variability in results achieved between different 
manufacturers even when assessing the same metabolites. A disadvantage of the TBARS 
colorimetric assay is that it can measure aldehydes other than MDA, and degrading fatty 
acids within a sample can influence the amount of MDA measured.36 Drawing on this 
knowledge and the earlier experiences with the TBARS assay we funded the state 
pathology service (Queensland Health Pathology Service) to setup and validate a HPLC 
column specifically for the analysis of MDA. The HPLC method allows the separation of the 
MDA-TBA adduct from interfering chromophores, producing results which are more specific 
for MDA.36 In addition, our studies may have been improved by incorporating additional 
measures of lipid, and protein, such as F2-isoprostanes and protein carbonyls. 
One of the more significant limitations of this thesis occurred in the ovine ECMO study and 
these have been touched on briefly in Chapter 6. ECMO typically lasts several days to 
several weeks, during which time there will be changes in the proteins and cells adhering to 
the ECMO circuit.27 Some of these proteins (e.g. albumin, selenoprotein P) are thought to 
be transport proteins for selenium,277 and certainly for albumin, are quickly deposited on the 
ECMO circuit surface upon first contact with blood. However, beyond 24 hrs there is some 
evidence that these proteins are no longer deposited on the circuit surface and blood levels 
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will remain stable.27 Equally, as the population of inflammatory cells adhering to the circuit 
surface changes over time this will ultimately change the level of ROS generation and the 
chronic redox status of the patients. As our study was only 24 hrs in duration we are unable 
to comment on the effects of ECMO on selenium and redox status in the long term. While 
the practicalities of running a longer animal model of ECMO were beyond the abilities of this 
research institution, this has to be recognized as a significant limitation of the study with 
respect to the clinically relevant conclusions that could be drawn. Despite the limitations in 
this study, the results do support conducting a similar clinical study over the full duration of 
ECMO and even into the rehabilitation period. Only in this manner will we gain a better 
understanding as to whether selenium levels (and redox status) are altered in a negative 
manner, or if they wax and wane with various interventions such as transfusion and dialysis, 
and if opportunistic infections occur only when selenium levels are at their lowest.  
The final limitation, which applies to the studies in chapter 5 and 6 is the use of human 
albumin as volume replacement in the ovine studies. There is no data comparing the use of 
human albumin in ovine studies and its potential effect on the inflammatory or oxidative 
stress response. In studies comparing human and bovine albumin the physical properties 
appear to be indistinguishable, yet despite this similarity there are differences regarding 
electrophoretic behaviour, thermal and chemical stability and some binding properties.278 
Equally albumin has been shown to have pro-inflammatory effects in vitro as well as 
immunomodulatory properties.279 The possibility that human albumin transfusion in an ovine 
model causes an inflammatory response (and therefore influencing oxidative stress) cannot 
be excluded and presents itself as a minor limitation in the studies of chapter 5 and 6.  
 
Considerations and Future Directions 
While the results from the collective studies of this thesis are clinically interesting, the 
challenge is in translating them into clinical practice. Currently selenium is not a routine test 
in the cardiac surgical or intensive care setting. The knowledge that low pre-operative 
selenium levels before cardiac surgery might increase risk of POAF or result in a longer ICU 
stay suggests that high-risk cardiac surgical patients may benefit from earlier screening of 
selenium levels. Hence, one of the post-PhD aims is to conduct a randomized controlled 
trial (n = 200) to investigate the potential benefits of high-dose selenium supplementation in 
patients with (pre-operatively) selenium levels ≤ 0.7 µmol/L. High doses of selenium have 
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been determined to be safe in this patient population25, but it remains to be confirmed if 
such high dose selenium supplementation might be associated with reductions in POAF.  
Despite the postulated benefits of selenium supplementation in the cardiac surgical and 
critically ill patient, the reported benefits of selenium as a monotherapy are variable,80,280 
(despite documented improvement in GPx activity). The latest Cochrane review in 2008 
regarding selenium supplementation in the critically ill noted that “no clear evidence 
emerged for ventilator time, length of intensive care unit stay, length of hospital stay or 
quality of life”.281 One problem cited in the review was poor methodological design, which 
involved deciding on the patient group to supplement, when to give the supplementation 
and at what dose. In 2009, the Canadian Critical Care Nutrition Guidelines reported that 
there was insufficient evidence to recommend the use of selenium supplements in the 
critically ill, even in combination with other antioxidants. A 2011 meta-analyses examined 
the benefit of selenium supplementation across 12 publications involving critically ill 
patients, concluding that selenium supplementation significantly reduced the risk of mortality 
among critically ill patients with SIRS or sepsis without evidence of adverse effects.234 In 
2013, the Canadian Critical Care Nutrition Guidelines were updated upgraded to say that 
“selenium supplementation in critically ill patients should be considered, alone or in 
combination.”86 However, the latest updated review in 2015 by the same committee 
reversed this decision, stating that “the use of IV/PN selenium supplementation, alone or in 
combination with other antioxidants, is not recommended in critically ill patients. The change 
in decision was based upon two additional studies, 282 and indicates how quickly 
recommendations can change based upon relatively small studies. One of these studies 
was under submission review (Bloos 2015) and was a multi-centre study of 33 ICU’s 
concluding that selenium had no effect on mortality, length of stay (ICU or hospital). The 
other single centre study randomized 40 severe septic patients to high dose Na-selenite or 
placebo. No beneficial effect was noted on clinical outcome, although selenium levels were 
restored.283 Despite this change of recommendation, the committee still expressed concern 
over the variability in study designs, selenium doing and patient populations. 282 It is 
therefore likely that as more evidence comes to light there will be further changes to the 
recommendations. As an example of how rapidly the position might change regarding 
selenium use in the critically ill, a recent study of 54 septic patients, (not reviewed by the 
Canadian Critical Care Nutrition committee), has shown a reduction in ventilator acquired 
pneumonia in mechanically ventilated patients with sepsis, although there was no change in 
28 day mortality.284 
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Many studies demonstrate that critically ill patients are hyper-metabolic, and it has even 
been suggested that as many as 50% of ECMO patients do not reach nutritional adequacy 
during treatment.271 Presumably the requirements for trace elements in these patients are 
elevated and indeed critically ill patients supplemented with a level of selenium far in excess 
of the daily upper limit exhibit no negative effects at all.273 The first step towards 
investigating the benefits of supplementation in the ECMO patient is to establish the time-
course changes in selenium over the duration of ECMO therapy. Indeed, in this thesis the 
ECMO studies in sheep identified profound early reductions of selenium,270 so now studies 
are needed to determine if the same occurs in patients over the duration of their ECMO 
support and hospital stay. In addition there are preliminary plans to investigate changes to 
the inflammatory and immune systems in ECMO patients, beginning the sampling at the 
initiation of ECMO and continuing to hospital discharge (in the survivors).  
Selenium, as an antioxidant supplement, is certain to remain of research interest in these 
patients groups. By incorporating the findings of this thesis to select and specifically target 
supplementation at patients with low selenium levels, it may be possible, to determine if 
there really is a clinical benefit to normalizing levels in cardiac surgical and ECMO patients. 
Therefore, this body of work has led to the following new research questions: 
 Do plasma selenium levels in the normal reference range provide adequate oxidative 
stress protection for cardiac surgery or ECMO patients, and do such levels also 
equate to optimal immune function and thyroid activity?  
 If not, what target plasma selenium level is required to protect cardiac surgical or 
ECMO patients from oxidative stress injury?  
 What dose of supplemental selenium is required to reach this target plasma selenium 
level? 
 When is the optimal time to give supplemental selenium in cardiac and ECMO 
patients?  
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